Top ▲
Ligand name | ID | Synonyms | |||||||
A | Back to top | ||||||||
852A |
![]() |
9025 | |||||||
A286982 |
![]() |
6592 | A 286982, A-286982 | ||||||
A438079 |
![]() |
4118 | A 438079, A-438079 | ||||||
AB928 |
![]() |
![]() |
11154 | AB-928 | |||||
abediterol |
![]() |
9326 | LAS-100977 | ||||||
abrocitinib |
![]() |
![]() |
![]() |
9991 | Cibinqo®, compound 25 [PMID: 29298069], PF-04965842, PF04965842 | ||||
ABT-737 |
![]() |
![]() |
8320 | ABT 737, ABT737, compound 2 [PMID 17256834] | |||||
AC430 |
![]() |
9177 | AC-430 | ||||||
acalabrutinib |
![]() |
![]() |
![]() |
8912 | ACP-196, Calquence®, Example 6 [US20140155385 A1] | ||||
ACT-1014-6470 |
![]() |
12326 | example 172 [WO2019137927A1], Ic-58 | ||||||
ACT-389949 |
![]() |
9511 | |||||||
ACT-660602 |
![]() |
12207 | ACT660602, compound 9j [PMID: 35947786] | ||||||
ACT-777991 |
![]() |
12584 | ACT777991, compound 8a [PMID: 36883854] | ||||||
acumapimod |
![]() |
9203 | BCT 197, BCT-197, BCT197, compound A [WO2013139809] | ||||||
adriforant |
![]() |
8985 | PF 3893787, PF-03893787, ZPL-389, ZPL-3893787, ZPL389, ZPL3893787 | ||||||
ADU-S100 |
![]() |
10192 | dithio-(Rp,Rp)-[cyclic[A(2',5')pA(3',5')p]], MIW815, ML RR-S2 CDA, S100 | ||||||
agatolimod |
![]() |
9843 | CpG 7909, CpG7909, PF 3512676, PF-3512676, ProMune, VaxImmune | ||||||
AGU654 |
![]() |
13646 | AGU-654, compound 44 [PMID: 39622054] | ||||||
AH10-7 |
![]() |
9899 | |||||||
AH6809 |
![]() |
1896 | AH 6809, AH-6809 | ||||||
AJ2-30 |
![]() |
13090 | compound 4 [PMID: 38191941] | ||||||
alcaftadine |
![]() |
![]() |
7587 | Lastacaft®, R-89674 | |||||
alimemazine |
![]() |
![]() |
7237 | Nedeltran®, trimeprazine | |||||
3 alpha-aminocholestane |
![]() |
9564 | 3AC, 3 α-aminocholestane | ||||||
alvelestat |
![]() |
6476 | AZD 9668, AZD-9668, AZD9668, KB-105160 | ||||||
AM-461 |
![]() |
10170 | AM461, Compound 1 [WO2011085033] | ||||||
amcinonide |
![]() |
![]() |
7060 | CL-34699, Cyclocort® | |||||
amelenodor |
![]() |
13384 | example 2 [WO2020010132A1], NX-13, NX13 | ||||||
amelubant |
![]() |
8463 | BIIL 284, BIIL-284 | ||||||
AMG319 |
![]() |
![]() |
8917 | AMG 319, AMG-319 | |||||
AMG487 |
![]() |
13071 | AMG 487, AMG-487, compound 47 [PMID: 17448658] | ||||||
aminopyridine 2 |
![]() |
10051 | |||||||
amiselimod |
![]() |
9319 | Example 1 [US20090137530], MT-1303, MT1303 | ||||||
amiselimod phosphate |
![]() |
9491 | amiselimod-P, MT-1303-P | ||||||
amlexanox |
![]() |
![]() |
![]() |
7113 | AA-673, Amlexanox®, Aphthasol®, CHX-3673 | ||||
ancriviroc |
![]() |
804 | SCH 351125, SCH-351125, SCH-C | ||||||
andrographolide |
![]() |
9675 | |||||||
apafant |
![]() |
1860 | WEB 2086 BS, WEB-2086 | ||||||
apilimod |
![]() |
9859 | LAM-002A (apilimod dimesylate), LAM002A, STA 5326, STA-5326, STA5326 | ||||||
apratastat |
![]() |
6482 | compound 5h [PMID: 16426848], TMI-05, TMI005 | ||||||
apremilast |
![]() |
![]() |
![]() |
7372 | CC-10004, Otezla® | ||||
AR-9281 |
![]() |
13112 | AR9281, compound 14a [PMID: 21211973] | ||||||
arformoterol |
![]() |
![]() |
![]() |
7479 | (-)-Formoterol, (R,R)-Formoterol, Brovana®, YM-08316 | ||||
ARN19702 |
![]() |
![]() |
10120 | ARN-19702, compound 8 [PMID: 27404798] | |||||
ARN726 |
![]() |
9178 | ARN-726, compound 6 [PMID: 25874594] | ||||||
(R)-ARN2508 |
![]() |
9000 | compound (-)-10r [PMID: 26774927], example 19 [WO2014023643] | ||||||
(S)-ARN2508 |
![]() |
![]() |
8999 | compound (+)-10r [PMID: 26774927], example 20 [WO2014023643] | |||||
arpromidine |
![]() |
1221 | ARP | ||||||
ARRY-371797 |
![]() |
11095 | ARRY-797, ARRY371797, ARRY797, compound 7 [PMID: 19950901] | ||||||
ARRY-382 |
![]() |
9108 | ARRY 382, ARRY382, c-Fms-IN-12, PF-07265804, PF07265804 | ||||||
ARRY-502 |
![]() |
10179 | ARRY502, example 237, enantiomer 1 [WO2009158426A1] | ||||||
AS101 |
![]() |
437 | ammonium tri-chloro(dioxoethylene-O,O'-)tellurate, AS 101, AS-101 | ||||||
AS-252424 |
![]() |
10578 | AS252424, compound 26 [PMID: 16789742] | ||||||
asapiprant |
![]() |
11951 | BGE-175, BGE175, example II-74 [US8153793B2], S-555739 | ||||||
asimadoline |
![]() |
9279 | EMD 61 753, EMD 61753, EMD-61753 | ||||||
asivatrep |
![]() |
9621 | Example 230 [US7858621], PAC-14028 | ||||||
ASP4058 |
![]() |
9569 | ASP-4058 | ||||||
aspirin |
![]() |
![]() |
![]() |
4139 | Acetophen®, acetylsalicylic acid, Aspirin® | ||||
AT38 |
![]() |
9020 | [3-(aminocarbonyl)furoxan-4-yl]methyl salicylate | ||||||
ATI-50001 |
![]() |
12317 | ATI-501, ATI50001, ATI501, example 103 [WO2007070872A1] | ||||||
atracurium |
![]() |
![]() |
9537 | atracurium besilate, atracurium dibesylate, BW 33A, Tracrium® | |||||
auranofin |
![]() |
![]() |
6306 | MMV688978, Ridaura®, SK&F-39162, SK-39162 | |||||
avacopan |
![]() |
![]() |
![]() |
9450 | CCX-168, CCX168, Tavneos® | ||||
avadomide |
![]() |
10522 | CC-122, CC122, Compound A [WO2014039960A1] | ||||||
avapritinib |
![]() |
![]() |
![]() |
10368 | Ayvakit®, Ayvakyt®, BLU-285, BLU285 | ||||
AVE 0991 |
![]() |
5579 | AVE-0991, AVE0991 | ||||||
AX-024 |
![]() |
11253 | AX-24, AX024 | ||||||
AZ13102909 |
![]() |
9577 | AZ909 | ||||||
AZ2 |
![]() |
![]() |
10233 | ||||||
AZ3451 |
![]() |
![]() |
9560 | ||||||
AZ7188 |
![]() |
9586 | |||||||
AZ8838 |
![]() |
![]() |
9585 | ||||||
azacitidine |
![]() |
![]() |
![]() |
6796 | 5-AZAC, 5-azacytidine, ladakamycin, Onureg®, Onureg® (CC-486; oral azacitidine), U-18496, Vidaza® | ||||
azatadine |
![]() |
![]() |
7119 | Optimine®, SCH-10649 | |||||
azathioprine |
![]() |
![]() |
7120 | Azasan®, BW-57-322, Imuran®, Jayempi® | |||||
AZD0284 |
![]() |
![]() |
11711 | AZD-0284, compound 20 [PMID: 34464130] | |||||
AZD1236 |
![]() |
7844 | AZD 1236, AZD-1236 | ||||||
AZD1678 |
![]() |
9679 | AZD-1678, compound 49 [PMID: 28947948] | ||||||
AZD1981 |
![]() |
7680 | AZD 1981, AZD-1981 | ||||||
AZD2098 |
![]() |
9678 | AZD-2098, compound 47 [PMID: 28947948] | ||||||
AZD2423 |
![]() |
7825 | AZD 2423, AZD-2423 | ||||||
AZD3458 |
![]() |
9997 | AZD-3458, compound 15 [PMID: 29852070] | ||||||
AZD3965 |
![]() |
10605 | AZD-3965 | ||||||
AZD5069 |
![]() |
8948 | AZD-5069 | ||||||
AZD5423 |
![]() |
![]() |
13017 | AZD-5423, compound 1b [PMID: 28937774] | |||||
AZD5672 |
![]() |
7686 | AZD 5672, AZD-5672 | ||||||
AZD5718 |
![]() |
10352 | compound 12 [PMID: 30869888] | ||||||
AZD6605 |
![]() |
7823 | AZ 11920155, AZ-11920155, AZ11920155, AZD 6605, AZD-6605 | ||||||
AZD6703 |
![]() |
![]() |
7687 | AZ 12012199, AZ-12012199, AZ12012199, AZD 6703, AZD-6703 | |||||
AZD7624 |
![]() |
11714 | AZD-7624, Example 259 [WO2009001132] | ||||||
AZD8154 |
![]() |
![]() |
11204 | AZD-8154, Example 1 [WO2018055040A1] | |||||
AZD8848 |
![]() |
9256 | DSP-3025 | ||||||
AZD9056 |
![]() |
7826 | AZD 9056, AZD-9056 | ||||||
AZD9567 |
![]() |
![]() |
9812 | AZD 9567, AZD-9567, compound 15 [PMID: 29424542], example 1 [WO2016046260A1] | |||||
AZD9898 |
![]() |
10479 | AZD-9898, example 62 [WO2016177845A1] | ||||||
azelaic acid |
![]() |
![]() |
![]() |
7484 | Azelex®, Finacea®, ZK-62498 | ||||
azithromycin |
![]() |
![]() |
![]() |
![]() |
6510 | ||||
AZ11657312 (salt free) |
![]() |
7722 | |||||||
B | Back to top | ||||||||
bafetinib |
![]() |
![]() |
7906 | INNO-406, Lyn-IN-1, NS-187 | |||||
balamapimod |
![]() |
9925 | MKI-833, MKI833 | ||||||
balinatunfib |
![]() |
13583 | SAR-441566, SAR441566 | ||||||
bardoxolone |
![]() |
2717 | CDDO, RTA-401 | ||||||
baricitinib |
![]() |
![]() |
![]() |
7792 | INCB-028050, INCB028050, LY-3009104, LY3009104, Olumiant® | ||||
BAY 11-7082 |
![]() |
5934 | (E)-3-tosylacrylonitrile, BAY-117082, BAY117082 | ||||||
BAY1830839 |
![]() |
![]() |
13101 | BAY-1830839, example 11 [WO2016083433A1] | |||||
BAY-985 |
![]() |
10597 | BAY985, compound 34 [PMID: 31859507] | ||||||
BAYu9773 |
![]() |
3381 | BAY u9773, BAY-u 9773 | ||||||
BC-1215 |
![]() |
12671 | BC 1215, BC1215 | ||||||
beclometasone |
![]() |
![]() |
![]() |
7059 | beclomethasone, SCH-18020W | ||||
beclometasone dipropionate |
![]() |
![]() |
5894 | beclomethasone dipropionate, Beconase®, Qnasl®, Vancenase® | |||||
belnacasan |
![]() |
9035 | HMR3480, VX-765 | ||||||
belumosudil |
![]() |
![]() |
![]() |
9558 | KD-025, KD025, Rezurock®, SLx 2119, SLx2119 | ||||
bentamapimod |
![]() |
9926 | AS-602801, AS602801, PGL-5001, PGL5001 | ||||||
benzodrocortisone |
![]() |
9731 | compound 1 [WO2013071010], hydrocortisone 17-benzoate | ||||||
3beta-Hydroxy-20(29)-lupene |
![]() |
9028 | Fagarasterol, Lupeol | ||||||
BI-1935 |
![]() |
9717 | BI 1935, example 3 [WO2007067836] | ||||||
BI-1950 |
![]() |
9719 | |||||||
BI-2545 |
![]() |
![]() |
9791 | BI2545, compound 19 [PMID: 29259743] | |||||
BI605906 |
![]() |
9357 | 3-Amino-4-(1,1-difluoro- propyl)-6-(4-methanesulfonyl- piperidin-1-yl)-thieno[2,3- b]pyridine-2-carboxylic acid amide, compound 115 [US20070293533] | ||||||
BI 653048 |
![]() |
9715 | (R)-39, BI 653048 BS H3PO4, BI-653048, BI653048 | ||||||
BI 665915 |
![]() |
9716 | BI-665915, compound 69 [PMID: 25671290] | ||||||
BI-6901 |
![]() |
9714 | BI 6901, BI 6901, BI6901, eut-22 | ||||||
BIIB068 |
![]() |
![]() |
11178 | BIIB-068, compound 1 [PMID: 32696648] | |||||
bimosiamose |
![]() |
9049 | compound 15e [PMID: 9544210], TBC 1269, TBC-1269, TBC1269 | ||||||
bindarit |
![]() |
11124 | AF-2838, AF2838 | ||||||
BIO-7488 |
![]() |
13341 | BIO7488 | ||||||
BIO-8169 |
![]() |
13355 | BIO8169, compound 2 [PMID: 38695469] | ||||||
BIRT 377 |
![]() |
9720 | BIRT-377 | ||||||
BML-281 |
![]() |
9664 | compound 3 [PMID: 18642892] | ||||||
BMS-1001 |
![]() |
10191 | BMS1001, Example 1001 [WO2015160641A2] | ||||||
BMS-1166 |
![]() |
9608 | compound 2c [PMID: 28613862], Example 1166 [WO2015160641A2] | ||||||
BMS-202 |
![]() |
![]() |
9607 | compound 1c [PMID: 28613862], PD1-PDL1 inhibitor 2 | |||||
BMS-345541 |
![]() |
5669 | BMS 345541, BMS345541 | ||||||
BMS-509744 |
![]() |
9994 | BMS 509744, BMS509744, compound 3 [PMID:16682193] | ||||||
BMS-561392 |
![]() |
6509 | BMS 561392, BMS561392, DPC-333 | ||||||
BMS-582949 |
![]() |
![]() |
7838 | BMS 582949, BMS582949, PS 540446, PS-540446, PS540446 | |||||
BMS-681 |
![]() |
![]() |
9430 | compound 13d [PMID: 25893046] | |||||
BMS-817399 |
![]() |
![]() |
9497 | compound 29 [PMID: 25101488] | |||||
BMS-986142 |
![]() |
![]() |
9857 | BMS986142, compound 14f [PMID: 27583770] | |||||
BMS-986166 |
![]() |
11493 | BMS986166, compound 14a [PMID: 30785748] | ||||||
BMS-986235 |
![]() |
11024 | BMS986235, compound 13c [PMID: 32407089], LAR-1219, LAR1219 | ||||||
BMS-986260 |
![]() |
![]() |
10662 | BMS986260, compound 10 [Velaparthi et al., 2020], Example 32' [WO2016140884A1] | |||||
BMS-986104 derivative 12 |
![]() |
11494 | compound 12 [PMID: 33492963] | ||||||
BMS-986104 derivative 24 |
![]() |
11495 | compound 24 [PMID: 33492963] | ||||||
bortezomib |
![]() |
![]() |
![]() |
![]() |
6391 | peptide boronate, PS-341, Velcade® | |||
bosutinib |
![]() |
![]() |
![]() |
5710 | Bosulif®, SK 606, SK-606, SKI 606 | ||||
branebrutinib |
![]() |
9869 | BMS-986195, BMS986195, Example 223 [US20160115126A1] | ||||||
brensocatib |
![]() |
9412 | AZD7986, compound 30, INS 1007, INS1007 | ||||||
brepocitinib |
![]() |
![]() |
10459 | compound 23 [PMID: 30113844], PF-06700841, PF06700841 | |||||
brimonidine (UK14304) |
![]() |
![]() |
![]() |
520 | Alphagan®, Lumify®, Mirvaso®, UK14,304, UK14304 | ||||
BRL-15572 |
![]() |
10 | BRL 15572, BRL-15,572, BRL15572 | ||||||
bromfenac |
![]() |
![]() |
![]() |
7131 | AHR-10282B, Bromday®, Prolensa®, Xibrom® | ||||
BTP2 |
![]() |
2438 | YM-58483 | ||||||
budesonide |
![]() |
![]() |
7434 | Entocort®, Eohilia® (budesonide oral suspension), Jorveza®, Pulmicort®, S-1320, Uceris® | |||||
BX 471 |
![]() |
767 | BX-471, BX-741 | ||||||
BX-795 |
![]() |
![]() |
8006 | BX 795, BX795 | |||||
C | Back to top | ||||||||
C108297 |
![]() |
9180 | Compound 52 [PMID:18226897] | ||||||
C1-27 |
![]() |
![]() |
10719 | GSTO1-IN-1 | |||||
C-176 |
![]() |
13136 | C-176 STING inhibitor | ||||||
C391 |
![]() |
9570 | compound 5 [PMID: 27994760] | ||||||
C646 |
![]() |
7004 | |||||||
cambritaxestat |
![]() |
![]() |
13506 | compound 9v [PMID: 27780639], CRT-0273750, CRT0273750, IOA-289 | |||||
canertinib |
![]() |
5675 | CI 1033, CI-1033, PD 183805 dihydrochloride | ||||||
carotegrast |
![]() |
10511 | HCA2969 | ||||||
carotegrast methyl |
![]() |
![]() |
10510 | AJM-300, AJM300, Carogra® | |||||
carprofen |
![]() |
![]() |
7141 | Ro-205720000 | |||||
CBS-3595 |
![]() |
9610 | |||||||
CC-885 |
![]() |
9224 | |||||||
CCR2-RA-[R] |
![]() |
![]() |
9431 | analog 49 (Dasse et al., 2007) | |||||
CCX354 |
![]() |
10164 | CCX 354, CCX-354, CCX-354-C | ||||||
CDP840 |
![]() |
9330 | CDP 840, CDP-840 | ||||||
CEE321 |
![]() |
12350 | CEE-321, compound 1e [PMID: 36657024] | ||||||
celecoxib |
![]() |
![]() |
![]() |
2892 | Celecox®, Elyxyb® (DFN-15; oral solution), Onsenal®, SC-58635, SC58635 | ||||
cenerimod |
![]() |
![]() |
9824 | ACT-334441 | |||||
cenicriviroc |
![]() |
801 | TAK 652, TAK-652, TAK652, TBR-652 | ||||||
cerdulatinib |
![]() |
![]() |
8957 | PRT 062070, PRT-062070, PRT-2070, PRT062070 | |||||
cetirizine |
![]() |
![]() |
1222 | Reactine®, Zyrtec® | |||||
CG200745 |
![]() |
10055 | CG-2, CG-200745, HDCG-0745 | ||||||
CGI1746 |
![]() |
![]() |
8066 | CGI 1746, CGI-1746 | |||||
CGI560 |
![]() |
9264 | CGI-560 | ||||||
CH-4051 |
![]() |
9844 | Formula (10) [WO2012078708A1] | ||||||
chloroquine |
![]() |
![]() |
![]() |
![]() |
5535 | Aralen®, chloraquine, Malaquin® | |||
CHMFL-BTK-11 |
![]() |
9516 | |||||||
cicaprost |
![]() |
1917 | ZK 96480, ZK-96480 | ||||||
ciclesonide |
![]() |
![]() |
7469 | Alvesco®, Omnaris®, RPR-251526 | |||||
ciforadenant |
![]() |
10190 | CPI-444, CPI444, V-81444, V81444 | ||||||
cilomilast |
![]() |
![]() |
7407 | SB-207499 | |||||
cintirorgon |
![]() |
10045 | compound 32J [WO2016201225A1], LYC-55716, LYC55716 | ||||||
cipemastat |
![]() |
6466 | Ro 28-2653 | ||||||
civorebrutinib |
![]() |
12868 | |||||||
clemastine |
![]() |
![]() |
6063 | HS-592, meclastin, Tavegil®, Tavist® | |||||
clemizole |
![]() |
![]() |
10285 | ||||||
clobenpropit |
![]() |
![]() |
1223 | VUF 9153, VUF-9153 | |||||
clobetasol propionate |
![]() |
![]() |
![]() |
7062 | CCI-4725, Clobex®, Dermovate®, GR 2/925, Temovate® | ||||
clobetasone |
![]() |
![]() |
9088 | Eumovate® | |||||
clodronic acid |
![]() |
![]() |
9605 | Bonefos®, Clasteon ®, clodronate, Loron® | |||||
clofazimine |
![]() |
![]() |
9184 | Lamprene® | |||||
clopidogrel (active metabolite) |
![]() |
1772 | |||||||
CM4620 |
![]() |
10087 | CM-4620, compound I [WO2016138472A1] | ||||||
CNX-774 |
![]() |
9266 | |||||||
colchicine |
![]() |
![]() |
![]() |
2367 | Colcrys®, methoxylated analogue of XD1, XD25 | ||||
compound 48/80 |
![]() |
![]() |
5531 | ||||||
compound 3a [Pipionne et al, 2018] |
![]() |
9965 | |||||||
compound 10a [PMID: 31283223] |
![]() |
10435 | |||||||
compound 12a [PMID: 29031075] |
![]() |
9684 | |||||||
compound 19a [PMID: 26506089] |
![]() |
9842 | |||||||
compound 8a [PMID: 23713581] |
![]() |
8856 | |||||||
compound 21b [PMID: 31136173] |
![]() |
10403 | |||||||
compound 5b [PMID: 29457898] |
![]() |
9835 | |||||||
compound 5b [PMID: 31287314] |
![]() |
10434 | |||||||
compound 18c [PMID: 25901531] |
![]() |
9227 | |||||||
compound 7c [PMID: 22041175] |
![]() |
9931 | |||||||
compound 8c [PMID: 28760529] |
![]() |
9671 | |||||||
Compound 9 [doi:10.26434/chemrxiv.7072592.v1] |
![]() |
10083 | |||||||
compound 17d [PMID: 23099093] |
![]() |
8196 | |||||||
compound 5d [PMID: 31335136] |
![]() |
10441 | Example 59 [WO2018121550] | ||||||
compound 7d [PMID: 29672049] |
![]() |
9937 | |||||||
compound 18e [PMID: 31670517] |
![]() |
![]() |
10549 | ||||||
compound 4e [PMID: 35546685] |
![]() |
12122 | CHF-6297, CHF6297, CHI 91040, CHI91040, p38α MAPK-IN-5 | ||||||
compound 5e [PMID: 28580438] |
![]() |
9712 | |||||||
compound 14f [PMID: 35063894] |
![]() |
11936 | |||||||
compound 20f [PMID: 28520415] |
![]() |
9961 | |||||||
compound 7f [PMID: 29191554] |
![]() |
![]() |
9794 | example 32 [WO2011078413] | |||||
compound 7f [PMID: 29283260] |
![]() |
9780 | |||||||
compound 2g [PMID: 27390066] |
![]() |
9682 | |||||||
compound 4g [PMID: 2680437] |
![]() |
9198 | |||||||
compound G1 [PMID: 36689364] |
![]() |
12354 | |||||||
compound 8ic [PMID: 19081254] |
![]() |
9478 | CCR4 Antagonist | ||||||
compound III [PMID: 24045148] |
![]() |
9709 | |||||||
compound II [PMID: 21329883] |
![]() |
9579 | |||||||
compound 16i [PMID: 31525963] |
![]() |
10502 | |||||||
compound 5i [PMID: 36542759] |
![]() |
12336 | |||||||
compound 9 [Kumar et al., 2019] |
![]() |
10448 | |||||||
compound 17l [PMID: 26288691] |
![]() |
10035 | |||||||
compound 29 [Moslin et al., 2017] |
![]() |
9992 | |||||||
compound 12p [Larson et al., 2017] |
![]() |
9690 | |||||||
compound 10 [PMID: 31411465] |
![]() |
10488 | example 8 (cis racemate) [WO2017060855A1] | ||||||
compound 11 [PMID: 29442501] |
![]() |
9819 | |||||||
compound 12 [PMID: 27448772] |
![]() |
![]() |
9453 | ||||||
compound 15 [PMID: 25411721] |
![]() |
9078 | example 252 [WO2007110237] | ||||||
compound 15 [PMID: 32045236] |
![]() |
10706 | |||||||
compound 16 [PMID: 26794040] |
![]() |
9223 | |||||||
compound 16 [PMID: 31525966] |
![]() |
10501 | |||||||
compound 17 [PMID: 29741897] |
![]() |
10005 | |||||||
compound 182 [PMID: 37500611] |
![]() |
![]() |
13005 | compound XI [PMID: 37500611] | |||||
compound 1 [PMID: 24930776] |
![]() |
9092 | DB36 | ||||||
compound 1 [PMID: 28611375] |
![]() |
9673 | |||||||
compound 1 [PMID: 31477924] |
![]() |
10481 | |||||||
compound 21 [PMID: 22802221] |
![]() |
6918 | 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt, C21 | ||||||
compound 21 [PMID: 24900635] |
![]() |
8187 | |||||||
compound 24 [PMID: 26987013 ] |
![]() |
9252 | |||||||
compound 25 [PMID: 28038940] |
![]() |
9700 | |||||||
compound 25 [PMID: 31260299] |
![]() |
10428 | |||||||
compound 25 [PMID: 32105470] |
![]() |
10718 | |||||||
compound 25 [PMID: 32687365] |
![]() |
11130 | |||||||
compound 26 [PMID: 31710475] |
![]() |
10602 | |||||||
compound 27 [PMID: 24900635] |
![]() |
10133 | |||||||
compound 28 [PMID: 28671460] |
![]() |
9670 | |||||||
compound 29 [PMID: 31934767] |
![]() |
10596 | |||||||
compound 2 [PMID: 28621538] |
![]() |
![]() |
11282 | example 727 [WO2012093101A1] | |||||
compound 31 [PMID: 31259550] |
![]() |
10417 | |||||||
compound 32 [PMID: 31638797] |
![]() |
10528 | example 69 [WO2016179460A1] | ||||||
compound 32 [PMID: 38047891] |
![]() |
13050 | |||||||
compound 36 [PMID: 21958547] |
![]() |
9391 | |||||||
compound 37 [PMID: 29193967] |
![]() |
9797 | |||||||
compound 39 [PMID: 31742400] |
![]() |
10585 | |||||||
compound 3 [PMID: 28603634] |
![]() |
9628 | |||||||
compound 3 [PMID: 29633584] |
![]() |
9960 | |||||||
compound 41 [PMID: 25000588] |
![]() |
9349 | |||||||
compound 41 [PMID: 31855425] |
![]() |
![]() |
10598 | ||||||
compound 43 [PMID: 26751273] |
![]() |
9492 | |||||||
compound 47 [PMID: 28737909] |
![]() |
9646 | |||||||
compound 49 [PMID: 36529947] |
![]() |
12355 | |||||||
compound 52 [PMID: 28541707] |
![]() |
10001 | |||||||
compound 76 [PMID: 28657314] |
![]() |
9609 | |||||||
compound 7 [PMID: 31381331] |
![]() |
10450 | |||||||
compound 8 [PMID: 25898023] |
![]() |
10498 | |||||||
compound 9 [PMID: 26006010] |
![]() |
9761 | |||||||
compound (S)-29 [PMID: 37606563] |
![]() |
12904 | |||||||
compound 2q [PMID: 30986068] |
![]() |
![]() |
10365 | example 2-8 [US20150353552] | |||||
compound 14 [Schnute et al., 2023] |
![]() |
12351 | |||||||
compound T.14 |
![]() |
10385 | |||||||
compound 8u [PMID: 31999451] |
![]() |
10682 | |||||||
compound 3v [PMID: 27390066] |
![]() |
9683 | |||||||
compound 1 [WO2012007375] |
![]() |
8084 | |||||||
compound 7 [WO2012007375] |
![]() |
8085 | |||||||
compound 71 [WO2018191577A1] |
![]() |
11203 | |||||||
compound XVI [PMID: 38863440] |
![]() |
13423 | |||||||
compound 25 [Zhang et al., 2020] |
![]() |
![]() |
10643 | example 6B [WO2014028600A2] | |||||
compound 15z [PMID: 38029358] |
![]() |
13044 | NLRP3 inhibitor 15z | ||||||
CORM-2 |
![]() |
9535 | |||||||
CP105696 |
![]() |
3368 | CP 105696, CP-105,696, CP-105696 | ||||||
CP-195543 |
![]() |
6155 | CP 195543, CP-195,543, CP195543 | ||||||
CP-412,245 |
![]() |
11809 | |||||||
CP-424,174 |
![]() |
11810 | CP-424174 | ||||||
CpdA (parent molecule) |
![]() |
11317 | |||||||
CPUY192018 |
![]() |
9710 | compound 18e [PMID: 26258437], compound 2 [PMID: 24512214] | ||||||
CR6086 |
![]() |
9845 | |||||||
CRAC channel inhibitor 5b [PMID: 26256403] |
![]() |
10042 | |||||||
CRAC channel inhibitor 1 [PMID: 26256403] |
![]() |
10041 | |||||||
crenolanib |
![]() |
![]() |
7882 | ARO-002, CP 868596, CP-868,596, CP-868596 | |||||
crisaborole |
![]() |
![]() |
9151 | AN 2728, AN2728, compound 5b [PMID: 19303290], Eucrisa®, Staquis® | |||||
crizotinib |
![]() |
![]() |
![]() |
4903 | (R)-crizotinib, PF 2341066, PF-02341066, PF-2341066, PF2341066, Xalkori® | ||||
cromoglicic acid |
![]() |
![]() |
7608 | cromoglycate, cromolyn, cromolyn sodium, FPL-670, Intal®, Opticrom®, sodium cromoglicate | |||||
CRX-555 |
![]() |
10091 | CRX555, N-[(3R)-3-(Octanoyloxy)myristoyl]-O-[2-[[(3R)-3-(octanoyloxy)myristoyl]amino]-3-O-[(3R)-3-(octanoyloxy)myristoyl]-4-O-phosphono-2-deoxy-beta-D-glucopyranosyl]-L-serine | ||||||
CU-CPT8m |
![]() |
![]() |
9795 | 7-(m-Tolyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide, compound 5 [PMID: 29155428] | |||||
CVN293 |
![]() |
13373 | CVN-293 | ||||||
CX549 |
![]() |
9701 | compound 63 [WO2016048861], CX-549 | ||||||
CXCR4 antagonist 22 |
![]() |
10146 | |||||||
CY-09 |
![]() |
10057 | |||||||
cyclic di-GMP |
![]() |
![]() |
13137 | Bis-(3'-5')-cyclic dimeric guanosine monophosphate, c-di-GMP, cGpGp, dyclic diguanylate monophosphate | |||||
CZ415 |
![]() |
9837 | compound 3 [PMID: 27563401], CZ-415 | ||||||
D | Back to top | ||||||||
D4476 |
![]() |
5940 | casein kinase I inhibitor, CK1 inhibitor, D 4476 | ||||||
dagrocorat |
![]() |
9650 | PF-00251802 | ||||||
danirixin |
![]() |
8500 | GSK-1325756B, GSK1325756, GSK1325756B | ||||||
dapansutrile |
![]() |
10056 | OLT-1177, OLT1177 | ||||||
darapladib |
![]() |
![]() |
6696 | SB 480848, SB-480848 | |||||
dasatinib |
![]() |
![]() |
![]() |
5678 | BMS 345825, BMS 354825, BMS 35482513, Sprycel® | ||||
DDR1/2 inhibitor 5n |
![]() |
![]() |
10105 | ||||||
decernotinib |
![]() |
![]() |
8309 | adelatinib, VRT-831509, VX-509 | |||||
deflazacort |
![]() |
![]() |
9477 | Emflaza®, MDL 458 | |||||
defoslimod |
![]() |
9024 | OM 174, OM-174 | ||||||
delgocitinib |
![]() |
![]() |
![]() |
9619 | Anzupgo®, Corectim®, ent-60, JTE-052, JTE052 | ||||
desloratadine |
![]() |
![]() |
![]() |
7157 | Clarinex®, SCH-34117 | ||||
desonide |
![]() |
![]() |
7066 | D-2083, Desowen® | |||||
deucravacitinib |
![]() |
![]() |
10432 | BMS-986165, BMS986165, compound 11 [PMID: 31318208}, Sotyktu®, Tyk2-IN-4 | |||||
deuruxolitinib |
![]() |
![]() |
11410 | CTP-543, CTP543, D8-ruxolitinib, Leqselvi® | |||||
dexamethasone |
![]() |
![]() |
![]() |
2768 | Decadron®, desametasone, fluormethylprednisolone | ||||
dezapelisib |
![]() |
9728 | compound 67 [PMID: 22924688], example 15 [WO2011008487], INCB 40093, INCB40093 | ||||||
DFV890 |
![]() |
13525 | DFV-890, IFM-2427, IFM2427 | ||||||
diamorphine |
![]() |
9082 | acetomorphine, diacetylmorphine, heroin | ||||||
diclofenac |
![]() |
![]() |
![]() |
2714 | Cataflam®, CGP-45840B, GP-45840, Voltaren®, Voltarol® | ||||
difamilast |
![]() |
![]() |
9776 | example 352 [WO2007058338], MM36, Moizerto®, OPA-15406 | |||||
diflapolin |
![]() |
10080 | |||||||
diflorasone diacetate |
![]() |
![]() |
7068 | Psorcon®, U-34865 | |||||
diflunisal |
![]() |
![]() |
![]() |
7162 | Dolobid® | ||||
difluprednate |
![]() |
![]() |
7474 | DFBA, Durezol®, W-6309 | |||||
dilmapimod |
![]() |
7815 | SB-681323 | ||||||
dimethyl fumarate |
![]() |
![]() |
![]() |
7045 | BG-12, BG00012, fumaric acid, Tecfidera® | ||||
dimethyl itaconate |
![]() |
9939 | dimethylitaconate, itaconic acid dimethyl ester | ||||||
dimetindene |
![]() |
![]() |
10101 | (+/-)-dimethindene, dimethindene, dimethpyrindene, Fenistil®, Vibrocil® | |||||
(S)-dimetindene |
![]() |
10104 | (+)-dimethindene, (+)-dimetindene, (S)-dimethindene | ||||||
diminazene |
![]() |
![]() |
10307 | Azidin®, Berenil®, Pirocide® | |||||
dinaciclib |
![]() |
7379 | SCH727965 | ||||||
diphenylpyraline |
![]() |
![]() |
7165 | Hispril® | |||||
diprovocim-1 |
![]() |
![]() |
10341 | compound 3 [PMID: 30272974] | |||||
diroleuton |
![]() |
![]() |
9775 | 8,11,14-Eicosatrienoic acid, DGLA, dihomo-gamma-linolenic acid, DS107, Homo-gamma-linolenic acid | |||||
diroximel fumarate |
![]() |
![]() |
10525 | ALKS-8700, ALKS8700, BIIB098, Vumerity® | |||||
DMAT |
![]() |
![]() |
9323 | 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole, CK2 Inhibitor II | |||||
DO264 |
![]() |
10250 | compound 46, DO-264 | ||||||
doramapimod |
![]() |
![]() |
5668 | BIRB 796BS, BIRB-796, BIRB796 | |||||
doxycycline |
![]() |
![]() |
![]() |
![]() |
6464 | BMY-28689, Monodox®, Vibramycin® | |||
dual sEH/FAAH inhibitor 11 |
![]() |
10124 | compound B-11 [WO2017160861], example 28 [WO2017160861] | ||||||
dubermatinib |
![]() |
8863 | compound 13, TP 0903, TP-0903, TP0903 | ||||||
duvelisib |
![]() |
![]() |
7795 | compound 4904 [Patent US8193182], Copiktra®, INK-1197, IPI-145 | |||||
E | Back to top | ||||||||
6E11 |
![]() |
9749 | |||||||
E-52862 |
![]() |
![]() |
10431 | compound 28 [PMID: 22784008], E52862, MR309, sigma 1 receptor antagonist (S1RA) | |||||
E6201 |
![]() |
![]() |
7836 | E 6201, E-6201 | |||||
edicotinib |
![]() |
8942 | JNJ-40346527, JNJ40346527, US8497376, 15 | ||||||
EG01377 |
![]() |
![]() |
9904 | (3-((5-(4-(aminomethyl)phenyl)-2,3-dihydrobenzofuran)-7-sulfonamido)thiophene- 2-carbonyl)-L-arginine, compound 1 [PMID: 29648813] | |||||
eganelisib |
![]() |
![]() |
9563 | compound 26 [PMID: 27660692], IPI-549, IPI549 | |||||
elenestinib |
![]() |
12357 | BLU-263, BLU263, exampl4 4 [WO2020210293A1] | ||||||
elsubrutinib |
![]() |
10464 | example #30 (S) [WO2014210255A1] | ||||||
elubirixin |
![]() |
8499 | SB 656933, SB-656933, SB656933 | ||||||
emavusertib |
![]() |
![]() |
10152 | AU-4948, AU4948, CA4948, compound 24 [PMID: 33335659] | |||||
emlenoflast |
![]() |
12172 | Inzomelid, MCC-7840, MCC7840 | ||||||
enexasogaol |
![]() |
9773 | 6-Shogaol, [6]-shogaol, trans-6-shogaol | ||||||
enpatoran |
![]() |
![]() |
11307 | compound 73 [WO2017106607A1], M-5049, M5049 | |||||
ensifentrine |
![]() |
![]() |
11865 | Ohtuvayre®, RPL554, VMX 554, VMX-554, VMX554 | |||||
epacadostat |
![]() |
![]() |
8221 | IDO inhibitor 1, INCB 24360, INCB-24360, INCB024360 | |||||
epinastine |
![]() |
![]() |
7176 | Elestat®, epinastine hydrochloride | |||||
ER-27319 |
![]() |
9611 | |||||||
esflurbiprofen |
![]() |
![]() |
![]() |
9420 | (S)-flurbiprofen, BTS-24332, SFPP, TT-063 | ||||
etodolac |
![]() |
![]() |
7185 | AY-24236, Lodine® | |||||
etoricoxib |
![]() |
![]() |
![]() |
2896 | Arcoxia®, MK 0663, MK-0663, MK0663 | ||||
etrasimod |
![]() |
![]() |
9331 | APD-334, APD334, APD334-003, compound 4 [PMID: 25516790], Velsipity® | |||||
everolimus |
![]() |
![]() |
5889 | Afinitor®, Certican®, RAD-001, RAD001, rapamycin, 42-O-(2-hydroxyethyl)-, Zortress® | |||||
evobrutinib |
![]() |
![]() |
9752 | A250 [WO2012170976], M-2951, M2951, MSC 2364447, MSC-2364447C, MSC2364447C | |||||
example 131 [WO2009133348] |
![]() |
8489 | |||||||
example 25 [WO2018228934] |
![]() |
10201 | |||||||
example 36 [WO2016177845] |
![]() |
9555 | |||||||
Example 4 [WO2017202275A1] |
![]() |
10449 | |||||||
F | Back to top | ||||||||
F16357 |
![]() |
9255 | Compound 39 [PMID: 19791800], Example 1 in WO2007147824 | ||||||
F215 |
![]() |
10121 | |||||||
fenebrutinib |
![]() |
![]() |
9299 | Example 130 [US20140194408], GDC-0853, GDC0853, RG-7845, RG7845 | |||||
fenoprofen |
![]() |
![]() |
4820 | fenoprofen calcium, Nalfon® | |||||
fevipiprant |
![]() |
![]() |
8995 | NVP-QAW039, QAW039 | |||||
fexofenadine |
![]() |
![]() |
4819 | Allegra®, fexofenadine HCl | |||||
filgotinib |
![]() |
![]() |
![]() |
7913 | GLPG-0634, GLPG0634, Jyseleca® | ||||
fimepinostat |
![]() |
8952 | CUDC 907, CUDC-907, PI3K/HDAC Inhibitor centn | ||||||
fingolimod |
![]() |
![]() |
2407 | FTY-720, FTY720, Gilenya® | |||||
FIPI |
![]() |
8781 | compound 14 [PMID: 19136975] | ||||||
firategrast |
![]() |
11486 | SB-683699, SB683699 | ||||||
fludroxycortide |
![]() |
![]() |
7606 | Cordran®, flurandrenolide, flurandrenolone, Haelan® | |||||
flufenamic acid |
![]() |
![]() |
![]() |
2447 | |||||
flumethasone pivalate |
![]() |
![]() |
7075 | Locorten® | |||||
flunisolide |
![]() |
![]() |
7076 | AeroBid®, RS-3999 | |||||
fluocinolone acetonide |
![]() |
![]() |
7077 | Capex®, Iluvien®, Synalar® | |||||
fluocinonide |
![]() |
![]() |
7078 | Fluonex®, Lidex® | |||||
fluorescent MIF ligand B |
![]() |
![]() |
9987 | ||||||
fluorometholone |
![]() |
![]() |
7079 | Flarex®, FML® | |||||
flurbiprofen |
![]() |
![]() |
4194 | Ansaid®, Froben® | |||||
fluticasone |
![]() |
![]() |
6699 | Advair®, Avamys®, Flovent HFA®, Veramyst® | |||||
fluticasone furoate |
![]() |
![]() |
![]() |
10892 | Arnuity Ellipta, Avamys, FF, Flonase Sensimist, Veramyst | ||||
fluticasone propionate |
![]() |
![]() |
7080 | Advair Diskus®, ArmonAir RespiClickTM, CCI-18781, Flovent® | |||||
fluvoxamine |
![]() |
![]() |
![]() |
7189 | Luvox®, U-23000 | ||||
FLX475 |
![]() |
12153 | example 43 [WO2018022992A1], FLX-475 | ||||||
formoterol |
![]() |
![]() |
3465 | BD-40A, CGP-25827A, Foradil®, Oxeze/Oxis®, YM-08316 | |||||
fosdagrocorat |
![]() |
9649 | PF-04171327 | ||||||
fosifidancitinib |
![]() |
10637 | |||||||
fostamatinib |
![]() |
![]() |
![]() |
7796 | R 788, R-788, R7935788, Tavalisse®, Tavlesse® | ||||
FR122047 |
![]() |
5191 | FR 122047, FR 122047 hydrochloride, FR-122047 | ||||||
friluglanstat |
![]() |
12888 | example 11 [US9216968B2] | ||||||
G | Back to top | ||||||||
gabapentin |
![]() |
![]() |
![]() |
5483 | CI 945, Go 3450, GOE 2450, GOE 3450, Neurontin® | ||||
Galapagos MAPKAPK5 inhibitor D |
![]() |
9848 | compound 183 [WO2007138072A2] | ||||||
gamcemetinib |
![]() |
12167 | CC-99677, CC99677 | ||||||
gandotinib |
![]() |
![]() |
7909 | LY-2784544, LY2784544 | |||||
GB88 |
![]() |
6658 | GB 88, GB-88 | ||||||
GDC-0214 |
![]() |
12318 | GDC0214, iJak-381, RG-6151, RG6151 | ||||||
GDC-0834 |
![]() |
![]() |
9263 | GDC 0834 | |||||
GDC-2394 |
![]() |
![]() |
12280 | compound 20 [PMID: 36279149], GDC2394 | |||||
gefapixant |
![]() |
![]() |
![]() |
9540 | AF-219, AF219, Lyfnua®, MK7264, MK‐7264 | ||||
GlcC14C18 |
![]() |
9483 | 6-O-(2'(R,S)-tetradecyloctadecanoyl)-D-glucose | ||||||
glibenclamide |
![]() |
![]() |
![]() |
2414 | Amglidia®, Diabeta®, glyburide, Glynase® | ||||
GLPG0974 |
![]() |
8417 | compound 99 [PMID 25380412] | ||||||
GLPG1205 |
![]() |
10171 | compound 122 [WO2013092791A1], GLPG-1205 | ||||||
GLPG3970 |
![]() |
12157 | compound 32 [PMID: 38552030], compound 88 [WO2019238424A1], GLPG-3970 | ||||||
glycopyrrolate |
![]() |
![]() |
7459 | AHR-504, Qbrexza® (glycopyrronium cloth), Robinul®, Seebri Neohaler®, Tovanor Breezhaler® | |||||
GNE-3500 |
![]() |
9660 | |||||||
GNE-4997 |
![]() |
![]() |
9995 | compound 28 [PMID: 25844760], GNE 4997, GNE4997 | |||||
GNE684 |
![]() |
![]() |
13107 | GNE-684 | |||||
GNF362 |
![]() |
9548 | example 71 [US20090306039] | ||||||
GR-389988 |
![]() |
10257 | Ex. 3-15 [US9174986B2], GR389988, GZ389988, GZ389988A | ||||||
Grp94 inhibitor 54 |
![]() |
10118 | |||||||
GSK065 |
![]() |
![]() |
10358 | GSK3335065, inhibitor C1 [PMID: 28604669] | |||||
GSK143 |
![]() |
9388 | compound 20 [PMID: 21903390] | ||||||
GSK1482160 |
![]() |
10504 | compound 1b [PMID: 31525963], compound 31 [PMID: 20673717], GSK-1482160 | ||||||
GSK2245035 |
![]() |
9254 | compound 32 [PMID: 26861551] | ||||||
GSK2256294 |
![]() |
9718 | GSK-2256294, GSK-2256294A, GSK2256294A | ||||||
GSK2292767 |
![]() |
![]() |
10633 | compound 2 [PMID: 30532965], compound 3 [PMID: 26301626], GSK-2292767 | |||||
GSK2646264 |
![]() |
![]() |
10108 | compound 44 [PMID: 30249354] | |||||
GSK2879552 |
![]() |
9116 | Example 26 [WO2012135113], GSK-2879552 | ||||||
GSK2981278 |
![]() |
9661 | |||||||
GSK2982772 |
![]() |
![]() |
9554 | compound 5 [PMID: 28151659] | |||||
GSK343 |
![]() |
![]() |
8240 | compound 6 [PMID 24900432], GSK 343 | |||||
GSK'547 |
![]() |
11274 | example 6 [WO2020044206A1], GSK-547, GSK547 | ||||||
GSK583 |
![]() |
![]() |
9134 | GSK'583 | |||||
GSK8612 |
![]() |
10343 | |||||||
GSK866 |
![]() |
![]() |
9653 | ||||||
GSK963 |
![]() |
10132 | GSK'963, GSK′963A | ||||||
GSK2239633A |
![]() |
10416 | compound 6 [PMID: 23409871], GSK-2239633A | ||||||
GSK-7975A |
![]() |
10088 | example 36 [US20120053150A1], GSK7975A | ||||||
GSK-J1 |
![]() |
![]() |
7027 | ||||||
GSK-J4 |
![]() |
8979 | GSK J4, GSKJ4 | ||||||
gusacitinib |
![]() |
10000 | ASN-002, ASN002, example 189 [WO2013028818A1] | ||||||
GW274150 |
![]() |
9849 | [2-[(1-iminoethyl) amino]ethyl]-L-homocysteine, GW-274150 | ||||||
GW3965 |
![]() |
![]() |
2754 | C473027, GW 3965, GW-3965 | |||||
GW406381 |
![]() |
9850 | compound 8 [PMID: 15454242], GW-406381 | ||||||
GW 627368 |
![]() |
1953 | GW-627368, GW627368, saccharic acid | ||||||
GW766994 |
![]() |
9680 | GSK766994, GW-766994 | ||||||
GYY4137 parent molecule |
![]() |
9808 | GYY4137 | ||||||
H | Back to top | ||||||||
H-151 |
![]() |
10122 | H 151, H151 | ||||||
H4 antagonist 48 |
![]() |
9879 | |||||||
HG-9-91-01 |
![]() |
![]() |
8049 | HY-15776 | |||||
HTMT |
![]() |
1273 | histamine-trifluoromethyl-toluidine, histamine-trifluoromethyltoluide, HTFMT | ||||||
hydroxychloroquine |
![]() |
![]() |
![]() |
7198 | Dolquine®, Plaquenil® | ||||
5-hydroxyindoleacetic acid |
![]() |
![]() |
11900 | ||||||
hydroxyzine |
![]() |
![]() |
7199 | Atarax®, hydroxyzine hydrochloride, hydroxyzine pamoate, Vistaril® | |||||
I | Back to top | ||||||||
iberdomide |
![]() |
![]() |
9618 | CC-220, compound 6 [PMID: 28425720] | |||||
ibrutinib |
![]() |
![]() |
![]() |
6912 | Imbruvica®, PCI-32765 | ||||
ibudilast |
![]() |
![]() |
![]() |
7399 | AV-411, KC-404, Ketas®, MN-166 | ||||
ibuprofen |
![]() |
![]() |
2713 | Advil®, Brufen®, ibuprofen lysine, ibuprofen sodium, Motrin®, Nurofen®, U-18573 | |||||
I-C11 |
![]() |
10374 | |||||||
IC-87114 |
![]() |
![]() |
9376 | IC87114 | |||||
icanbelimod |
![]() |
![]() |
12098 | compound 2 [WO2015039587A1], S1p-receptor-agonist-1, YUN88562 | |||||
IcatCXPZ-01 |
![]() |
11179 | compound 8a [PMID: 30978322], XPZ-01 | ||||||
idelalisib |
![]() |
![]() |
![]() |
6741 | CAL-101/CAL101, GS-1101, Zydelig® | ||||
ifidancitinib |
![]() |
10638 | A-301, ATI-50002, ATI-502 | ||||||
iguratimod |
![]() |
![]() |
![]() |
9736 | Careram®, Iremod, Kolbet®, T-614 | ||||
IKK-beta inhibitor R-28 |
![]() |
10134 | (R)-28, example 225 [US8372875B2] | ||||||
IKK-2 inhibitor IV |
![]() |
![]() |
5986 | TPCA-1, TPCA1 | |||||
iloprost |
![]() |
![]() |
1895 | Aurlumyn®, Ventavis® | |||||
imaradenant |
![]() |
![]() |
11153 | AZD-4635, AZD4635 | |||||
imatinib |
![]() |
![]() |
![]() |
5687 | CGP 57148, Gleevec®, Glivec®, STI571 | ||||
imetit |
![]() |
![]() |
1250 | ||||||
imiquimod |
![]() |
![]() |
![]() |
5003 | Aldara®, R837, S-26308, Zyclara® | ||||
immepip |
![]() |
![]() |
1251 | ||||||
impromidine |
![]() |
1226 | SK&F-92676-A3 | ||||||
INCB3284 |
![]() |
9045 | compound 13 [PMID: 24900329], INCB 3284 | ||||||
INCB8761 |
![]() |
9032 | compound 17 [PMID: 24900280], INCB-8761, PF-4136309, PF4136309 | ||||||
indacaterol |
![]() |
![]() |
7455 | Arcapta Neohaler®, Onbrez®, QAB-149, QAB149 | |||||
indole-3-carbinol |
![]() |
![]() |
10047 | 3-hydroxymethylindole, 3-indolemethanol, 3-indolylcarbinol, I3C | |||||
indomethacin |
![]() |
![]() |
![]() |
1909 | Indocid®, Indocin® | ||||
inhibitor M9 [PMID: 38236416] |
![]() |
13113 | |||||||
inhibitor 32 [PMID: 29620892] |
![]() |
9898 | |||||||
ipratropium |
![]() |
![]() |
325 | Atrovent®, Ipraxa® | |||||
iptacopan |
![]() |
![]() |
![]() |
10710 | compound 41 [PMID: 32073845], Fabhalta®, LNP-023, LNP023 | ||||
IRAK-1/4 inhibitor |
![]() |
5990 | |||||||
IRAK4 inhibitor 4b [PMID: 18474425] |
![]() |
![]() |
8080 | ||||||
IRAK4 inhibitor rac-45 [PMID: 18501603] |
![]() |
8081 | |||||||
ISO-1 |
![]() |
9984 | IN1228 | ||||||
isoetarine |
![]() |
![]() |
7205 | Bronkometer®, Bronkosol®, WIN-3406 | |||||
isothiourea-1t |
![]() |
![]() |
2899 | IT1t | |||||
itacitinib |
![]() |
![]() |
8364 | Examlpe 294 [WO2011112662], INCB-039110 | |||||
ivarmacitinib |
![]() |
11878 | example 34 [WO2013091539A1], SHR-0302, SHR0302 | ||||||
izencitinib |
![]() |
10458 | example 1 [WO2016191524A1], JNJ-8398, JNJ8398, TD-1473, TD1473 | ||||||
J | Back to top | ||||||||
JAK3 inhibitor 32 |
![]() |
10156 | compound 32 [PMID: 30423248] | ||||||
JAK3 inhibitor 34 |
![]() |
![]() |
10157 | compound 34 [PMID: 30423248] | |||||
JAK inhibitor 20a |
![]() |
10147 | |||||||
JAK inhibitor 17b |
![]() |
10148 | |||||||
JNJ-10191584 |
![]() |
1277 | compound 12, JNJ 10191584, VUF 6002, VUF6002 | ||||||
JNJ-10311795 |
![]() |
6563 | |||||||
JNJ-27141491 |
![]() |
10586 | JNJ27141491 | ||||||
JNJ-39758979 |
![]() |
8984 | JNJ 39758979, JNJ39758979 | ||||||
JNK inhibitor IX |
![]() |
5996 | AC1LG8KT, BAS 01816608, TCS JNK 5a | ||||||
JR14a |
![]() |
10595 | |||||||
K | Back to top | ||||||||
KA1010 |
![]() |
9663 | |||||||
KBP-7018 |
![]() |
9691 | compound 3 [Huang et al., 2017] | ||||||
ketoprofen |
![]() |
![]() |
4795 | Actron®, Orudis® | |||||
ketorolac |
![]() |
![]() |
6661 | Acular®, Toradol® | |||||
KML29 |
![]() |
9482 | |||||||
KT-109 |
![]() |
10245 | KT109 | ||||||
KT-474 |
![]() |
12892 | Compound A [WO2022174269A1], KT474 | ||||||
L | Back to top | ||||||||
L-798,106 |
![]() |
1941 | L-798106, L798106 | ||||||
labuxtinib |
![]() |
12870 | Compound 1 [WO2022109595], example F91 [WO2013033070] | ||||||
lanraplenib |
![]() |
![]() |
9764 | compound 39 [PMID: 32292557], Ex.-2, US9290505, example 2 [US9290505], GS-9876, GS9876 | |||||
LASSBio-1524 |
![]() |
11066 | |||||||
LASW1393 |
![]() |
![]() |
10527 | compound 34 [PMID: 31609613], LASW-1393 | |||||
lazucirnon |
![]() |
10653 | AKST-4290, AKST4290, ALK-4290, ALK4290, Example 11 [WO2012045803A1] | ||||||
leflunomide |
![]() |
![]() |
6825 | Arabloc®, Arava®, HWA 486, HWA-486, lefunamide, SU-101 | |||||
lenabasum |
![]() |
![]() |
9772 | ajulemic acid, CPL-7075, CPL7075, CT-3, IP-751, IP751 | |||||
lenalidomide |
![]() |
![]() |
7331 | CC-5013, CDC-501, Revlimid® | |||||
leniolisib |
![]() |
![]() |
![]() |
9424 | CDZ-173, CDZ173, Example 67 [WO2012004299], Joenja® | ||||
LEO 134310 |
![]() |
11901 | LEO-134310, LEO134310 | ||||||
LEO 239652 |
![]() |
![]() |
12725 | compound 40 [PMID: 33054196], LEO-239652, LEO239652 | |||||
LEO 29102 |
![]() |
12724 | compound 20 [PMID: 24984230], LEO-29102, LEO29102 | ||||||
L-161,982 (EP4A) |
![]() |
1952 | EP4A, L-161982, L161982 | ||||||
lepzacitinib |
![]() |
12871 | example 117 [WO2019090158A1] | ||||||
lestaurtinib |
![]() |
![]() |
5672 | CEP-701, KT-5555, SP924 | |||||
levosalbutamol |
![]() |
![]() |
![]() |
9816 | (-)-albuterol, (-)-salbutamol, (R)-salbutamol, levalbuterol, Xopenex® | ||||
LFM-A13 |
![]() |
9262 | α-cyano-beta-hydroxy-β-methyl-N-(2, 5-dibromophenyl)propenamide, alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide | ||||||
L6H21 |
![]() |
9027 | |||||||
LHVS |
![]() |
9298 | morpholinurea-leucine-homophenylalanine-vinylsulfone-phenyl, morpholinurea-leucine-homophenylalaninevinyl phenyl sulfone | ||||||
lifitegrast |
![]() |
![]() |
7533 | compound 1g [PMID: 24900456], SAR 1118, SAR-1118, SAR-1118-023, Xiidra® | |||||
linrodostat |
![]() |
9707 | BMS-986205, BMS986205, Compound 2 [PMID: 29531094], Example 19 [US20160137652A1] | ||||||
lisofylline |
![]() |
9225 | (R)-lisophylline, CT-1501R | ||||||
LIT-927 |
![]() |
10075 | compound 57 [PMID: 30106292] | ||||||
LM10 |
![]() |
9016 | LM-10 | ||||||
lodoxamide |
![]() |
![]() |
![]() |
9743 | Alomide® | ||||
lomedeucitinib |
![]() |
13210 | BMS-986322, BMS986322, example 252 [US20210253554] | ||||||
londamocitinib |
![]() |
11716 | AZD-4604, AZD4604, example 35 [WO2018134213A1], Jak1-IN-7 | ||||||
lonodelestat |
![]() |
11275 | cyclo[Ala-Ser-Ile-Pro-Pro-Gln-Lys-Tyr-D-Pro-Pro-Nle(Bu)-Glu-Thr], POL-6014, POL6014 | ||||||
loratadine |
![]() |
![]() |
7216 | Claritin®, SCH-29851 | |||||
lorecivivint |
![]() |
9620 | adavivint (deprecated INN), SM0-4690, SM04690 | ||||||
losmapimod |
![]() |
7835 | GS856553, GW856553 | ||||||
5-LOX inhibitor 2m [PMID: 30199704] |
![]() |
10079 | |||||||
lumiracoxib |
![]() |
![]() |
![]() |
2897 | Prexige® | ||||
LW106 |
![]() |
9940 | |||||||
LX2931 |
![]() |
9851 | LX3305 | ||||||
LY255283 |
![]() |
3351 | CGS 23356, LY 255283, LY-255283 | ||||||
LY3023703 |
![]() |
![]() |
12211 | compound 9 [PMID: 25260492] | |||||
LY3509754 |
![]() |
13164 | |||||||
LYS006 |
![]() |
![]() |
11205 | LYS-006 | |||||
M | Back to top | ||||||||
3M-002 |
![]() |
![]() |
9270 | CL-075, CL075 | |||||
MAPK13-IN-1 |
![]() |
![]() |
11096 | compound 61 [WO2014015056A2] | |||||
mapracorat |
![]() |
9654 | BOL-303242-X, ZK-245186, ZK245186 | ||||||
maraviroc |
![]() |
![]() |
806 | Celsentri®, Selzentry®, UK 427857, UK-427,857 | |||||
marbostat-100 |
![]() |
9891 | compound 5a [PMID: 29589441] | ||||||
maresin 1 |
![]() |
12056 | 7R,14S-dihydroxydocosa-4Z,8E,10E,12Z,16Z,19Z-hexaenoic acid, 7R-Maresin 1, MaR1, Maresin-1 | ||||||
maresin 2 |
![]() |
12055 | 13R,14S-diHDHA, 13R,14S-dihydroxy-docosahexaenoic acid, MaR2, maresin-2 | ||||||
masitinib |
![]() |
![]() |
5656 | AB-1010, AB1010, Masican® (proposed trade name) | |||||
mavorixafor |
![]() |
![]() |
8580 | AMD 070, AMD-070, AMD-11070, AMD11070, compound 2 [PMID: 20297846], X4P-001, X4P-001-IO, X4P-001-LD, Xolremdi® | |||||
MCC950 |
![]() |
![]() |
8228 | CP-456,773, CP-456773, CRID3, MCC-950 | |||||
MDG 548 |
![]() |
9888 | compound 1 [PMID: 22582973], MDG-548, MDG548 | ||||||
meclofenamic acid |
![]() |
![]() |
![]() |
7219 | CL-583, INF-4668, Meclomen® | ||||
mefenamic acid |
![]() |
![]() |
![]() |
2593 | CI-473, CN-35355, INF-3355, Ponstan®, Ponstel® | ||||
meloxicam |
![]() |
![]() |
![]() |
7220 | Mobic®, UHAC-62XX | ||||
mepacrine |
![]() |
![]() |
![]() |
10172 | Atabrine®, quinacrine | ||||
mepyramine |
![]() |
![]() |
![]() |
1227 | Anthisan®, mepiramine, mepyramine maleate, pyrilamine, pyrilamine tannate, Pyrlex® | ||||
merestinib |
![]() |
![]() |
9841 | LY-2801653, LY2801653 | |||||
mesalazine |
![]() |
![]() |
2700 | 5-aminosalicylic acid, 5-ASA, mesalamine (USAN), Pentasa® | |||||
metformin |
![]() |
![]() |
![]() |
4779 | Glucophage®, LA-6023 | ||||
methacholine |
![]() |
![]() |
7438 | methacholine bromide, Provocholine® | |||||
methimazole |
![]() |
![]() |
![]() |
6649 | Tapazole®, Thiamazole® | ||||
methotrexate |
![]() |
![]() |
![]() |
4815 | Abitrexate®, amethopterin, Nordimet®, Rasuvo® | ||||
(R)-α-methylhistamine |
![]() |
1236 | (R)-α-MeHA, alpha-methylhistamine | ||||||
MIDD0301 |
![]() |
9890 | |||||||
midostaurin |
![]() |
![]() |
![]() |
5702 | CGP 41231, CGP 41251, N-benzoylstaurosporine, PKC412, Rydapt® | ||||
mifepristone |
![]() |
![]() |
![]() |
2805 | Mifeprex®, RU-486, RU486 | ||||
MIF inhibitor 3bb |
![]() |
![]() |
9986 | ||||||
milategrast |
![]() |
10463 | example 9 [US20050261291A1] | ||||||
miltefosine |
![]() |
![]() |
11355 | D-18506, D18506, Impavido®, Miltex®, n-hexadecylphosphorylcholine | |||||
mivavotinib |
![]() |
![]() |
9600 | compound 3b [PMID: 27839918], TAK-659, TAK659 | |||||
mizolastine |
![]() |
![]() |
10102 | Mizollen®, MKC-431, MKC431, SL 85.0324, SL-850324, SL850324 | |||||
MK-0359 |
![]() |
9852 | L-454,560, L-454560, MK0359 | ||||||
MK-0812 |
![]() |
9048 | MK0812 | ||||||
MK-0873 |
![]() |
9853 | compound 20 [PMID: 18835163], MK0873 | ||||||
MK-886 |
![]() |
![]() |
2655 | L 663536, MK886 | |||||
ML130 |
![]() |
8887 | compound 1c [PMID: 22003428], ML-130, Noditinib-1 | ||||||
ML324 |
![]() |
![]() |
9584 | ML-324, MMV1580488 | |||||
MLN-120B |
![]() |
5694 | ML120B, MLN120B | ||||||
ML2-SA1 |
![]() |
10301 | EVP-22, EVP22, ML2 SA1, ML2SA1 | ||||||
MM-433593 |
![]() |
9944 | MM433593 | ||||||
mocravimod |
![]() |
9727 | compound 2 [PMID: 23124563], KRP-203, KRP203 | ||||||
mocravimod-phosphate |
![]() |
2923 | KRP 203-phosphate, KRP203-phosphate | ||||||
mofegiline |
![]() |
9754 | MDL 72974, MDL-72,974, MDL-72974A | ||||||
molibresib |
![]() |
![]() |
7033 | CS-0717, GSK 525762A, GSK-525762, GSK525762, I-BET-762, I-BET762 | |||||
mometasone |
![]() |
![]() |
9029 | Elocon® (topical), Nasonex® | |||||
monomethyl fumarate |
![]() |
![]() |
5786 | methyl hydrogen fumarate | |||||
montelukast |
![]() |
![]() |
![]() |
3340 | Singulair® | ||||
mosedipimod |
![]() |
9771 | EC-18, Plag, (+/-) | ||||||
motolimod |
![]() |
9026 | VTX-2337 | ||||||
MPI-0485520 |
![]() |
9580 | MPC-9528, MPI-485520 | ||||||
MPPA |
![]() |
9897 | inhibitor 23 [PMID: 29614224] | ||||||
MRI-1867 |
![]() |
10521 | (-)-MRI-1867, MRI1867 | ||||||
MRL-248 |
![]() |
9080 | |||||||
MRL-367 |
![]() |
9079 | |||||||
MRL-871 |
![]() |
![]() |
10642 | MRL871 | |||||
MRS2578 |
![]() |
1753 | MRS 2578, MRS-2578 | ||||||
MRS4458 |
![]() |
9998 | compound 20 [Yu et al., 2018] | ||||||
MRS4478 |
![]() |
9999 | compound 30 [Yu et al., 2018] | ||||||
MRT67307 |
![]() |
![]() |
8062 | MRT-67307 | |||||
MW150 |
![]() |
![]() |
10524 | compound 11 [PMID: 30978288], compound 27 [WO2014145485A2], compound 8 [PMID: 25676389], MW-150, MW01-18-150SRM | |||||
mycophenolate mofetil |
![]() |
![]() |
6831 | Cellcept®, RS-61443, RS-61443-190 | |||||
N | Back to top | ||||||||
nabumetone |
![]() |
![]() |
![]() |
7245 | BRL-14777, Relafen® | ||||
nacresertib |
![]() |
13502 | compound 001 [WO2021057785] | ||||||
naproxcinod |
![]() |
9551 | AZD-3582, AZD3582, HCT-3012, NO-naproxen | ||||||
naproxen |
![]() |
![]() |
![]() |
5230 | (S)-naproxen, Aleve®, Naprosy® | ||||
navamepent |
![]() |
9463 | RX-10045 | ||||||
navarixin |
![]() |
8497 | MK-7123, MK7123, SCH-527123, SCH527123 | ||||||
navoximod |
![]() |
![]() |
9019 | GDC-0919, NLG-919, NLG919, RG6078 | |||||
NBI-74330 |
![]() |
839 | (±)-NBI 74330, NBI74330 | ||||||
NC1 |
![]() |
10373 | |||||||
NCX-4016 |
![]() |
9018 | NCX 4016, NCX4016, nitric oxide-releasing aspirin, nitroaspirin | ||||||
ND-2110 |
![]() |
![]() |
8082 | ||||||
ND-2158 |
![]() |
8083 | |||||||
NDT-19795 |
![]() |
13009 | NDT19795 | ||||||
NDT9513727 |
![]() |
![]() |
9746 | NDT 9513727, NDT-9513727 | |||||
necrostatin-1 |
![]() |
9750 | methyl-thiohydantoin-tryptophan, MTH-DL-tryptophan, MTH-trp, nec-1, Necrostatin 1 | ||||||
necrostatin-1s |
![]() |
9751 | 7-Cl-O-Nec-1, nec-1s, necrostatin 2 racemate | ||||||
nedocromil |
![]() |
![]() |
7607 | FPL-59002, nedocromil sodium, Rapitil®, Tilade® | |||||
neflamapimod |
![]() |
![]() |
5719 | VD-31745, VRT-031745, VX 745, VX-745 | |||||
nemiralisib |
![]() |
![]() |
9425 | compound 2 [PMID: 26301626], GSK-2269557, GSK2269557 | |||||
neoceptin-3 |
![]() |
![]() |
9137 | ||||||
neoceptin-4 |
![]() |
9138 | |||||||
NE 52-QQ57 |
![]() |
10206 | example 35 [WO2012131633A1], GPR4 antagonist 13, NE52-QQ57 | ||||||
nerandomilast |
![]() |
12518 | BI 1015550, BI-1015550, BI1015550 | ||||||
α-NETA |
![]() |
9781 | |||||||
Nexinhib20 |
![]() |
9419 | |||||||
nezulcitinib |
![]() |
11304 | example 1 [WO2020051105A1] | ||||||
NF-56-EJ40 |
![]() |
![]() |
10519 | ||||||
nibrozetone |
![]() |
13184 | ABDNAZ, RRx-001, RRx001 | ||||||
niflumic acid |
![]() |
![]() |
![]() |
2439 | |||||
NIK inhibitor 12f |
![]() |
10947 | |||||||
NIK SMI1 |
![]() |
9964 | |||||||
nimesulide |
![]() |
![]() |
![]() |
7401 | R-805 | ||||
N-methyl-2-pyrrolidone |
![]() |
![]() |
9520 | NMP, N-methyl-pyrrolidone | |||||
6-n-octylaminouracil |
![]() |
5846 | 6-n-octyl aminouracil | ||||||
NP3-253 |
![]() |
13645 | compound 16 [PMID: 39574318], NP3253 | ||||||
NPT520-34 |
![]() |
13271 | compound 1 [WO2019246454] | ||||||
NS-398 |
![]() |
![]() |
8976 | NS 398 | |||||
NS6180 |
![]() |
9318 | |||||||
NS6740 |
![]() |
11383 | A-793394, A793394, NS-6740 | ||||||
NSC61610 |
![]() |
10364 | |||||||
NSC80734 |
![]() |
10497 | |||||||
NT-0249 |
![]() |
13338 | NT0249 | ||||||
NT-0796 |
![]() |
13008 | NT0796 | ||||||
NX-2127 |
![]() |
12519 | |||||||
NX-5948 |
![]() |
12898 | compound 195 [WO2021113557A1], NX5948 | ||||||
O | Back to top | ||||||||
obatoclax |
![]() |
11086 | GX-15-070, GX15-070, obatoclax mesylate, SB16622 | ||||||
ocadusertib |
![]() |
13504 | compound I-30 [WO2021046407], LY-3871801, LY3871801, R-552, R552 | ||||||
oclacitinib |
![]() |
9696 | Apoquel® (veterinary use), PF-03394197 | ||||||
17-octadecynoic acid |
![]() |
8851 | 17-ODYA | ||||||
OD36 |
![]() |
![]() |
10406 | ||||||
ofirnoflast |
![]() |
13227 | example 10 [WO2021242505] | ||||||
olaptesed pegol |
![]() |
9674 | NOX-A12 | ||||||
olinciguat |
![]() |
10213 | IW-1701, IW1701 | ||||||
olodaterol |
![]() |
![]() |
![]() |
7543 | BI-1744, BI-1744-CL, Striverdi® | ||||
olopatadine |
![]() |
![]() |
7249 | ALO-4943A, KW-4679, Opatanol®, Patanol®, Pazeo® | |||||
olverembatinib |
![]() |
![]() |
![]() |
10630 | compound 10a [PMID: 23301703], GZD-824, GZD824, HQP-1351, HQP1351 | ||||
omaveloxolone |
![]() |
![]() |
7573 | RTA 408, RTA-408, Skyclarys® | |||||
4-OMe-ARM1 |
![]() |
![]() |
10562 | compound 7 [PMID: 31751136] | |||||
omilancor |
![]() |
10363 | analogue 7 [PMID: 27933891], BT-11, BT11, Example 1 [US9556146B2] | ||||||
omipalisib |
![]() |
![]() |
8974 | GSK 2126458, GSK-2126458, GSK2126458 | |||||
ONC201 |
![]() |
9978 | ONC-201, TIC-10, TIC10 | ||||||
ONO-AE3-208 |
![]() |
1942 | ONO AE3 208 | ||||||
ONX-0914 |
![]() |
9031 | PR-957 | ||||||
orelabrutinib |
![]() |
![]() |
10629 | example 3 [WO2015048662A2], ICP-022, ICP022 | |||||
ORG 214007-0 |
![]() |
11310 | [(-)-N-(2S,10S,14bS)]-N-(8-cyano-1,2,3,4,10,14b-hexahydro-10-methyl dibenzo[c,f]pyrido[1,2-a]azepin-2-yl)-4-methyl-1,2,3-thiadiazole-5-carboxamide]], ORG214007-0 | ||||||
Orita-13 |
![]() |
![]() |
9985 | compound 13 [PMID: 11170644] | |||||
otenaproxesul |
![]() |
9534 | ATB 346, ATB-346, ATB-346, (S)-, ATB346 | ||||||
oxaprozin |
![]() |
![]() |
![]() |
7252 | Daypro®, WY-21743 | ||||
ozagrel |
![]() |
![]() |
9866 | Cataclot®, KCT-0809, OKY-046, Pulmoza® | |||||
ozanimod |
![]() |
![]() |
![]() |
8709 | RPC-1063, RPC1063, Zeposia® | ||||
P | Back to top | ||||||||
P505-15 |
![]() |
![]() |
8070 | BIIB057, PRT-062607, PRT062607 | |||||
pamapimod |
![]() |
![]() |
9915 | compound 2b [PMID: 21375264], Ro 4402257, Ro-4402257, Ro4402257 | |||||
parecoxib |
![]() |
![]() |
![]() |
2895 | Dynastat®, SC-69124 | ||||
parsaclisib |
![]() |
10098 | compound 20 [PMID: 31749910], IBI376, INCB-050465 | ||||||
PBF-509 |
![]() |
10193 | PBF509 | ||||||
PBT-3 |
![]() |
9755 | |||||||
PCA 4248 |
![]() |
6080 | PCA-4248, PTEMC | ||||||
PDE4 inhibitor 16 |
![]() |
![]() |
10400 | ||||||
pecazine |
![]() |
![]() |
9782 | mepazine, nothiazine, Pacatal® | |||||
peficitinib |
![]() |
![]() |
8315 | ASP015K, JNJ-54781532 | |||||
pelubiprofen |
![]() |
9876 | compound 13b [PMID: 6607354], CS-670, DW-330SR, DW330SR, RS-2131 | ||||||
penicillamine |
![]() |
![]() |
![]() |
7264 | Cuprimine® | ||||
peptide 1 [PMID: 31774287] |
![]() |
10594 | |||||||
petesicatib |
![]() |
9855 | RG-7625, RG7625, RO-5459072 | ||||||
PF-03715455 |
![]() |
![]() |
8179 | ||||||
PF-04191834 |
![]() |
9054 | PF 4191834, PF-4191834 | ||||||
PF-04418948 |
![]() |
5817 | PF 04418948, PF04418948 | ||||||
PF-04634817 |
![]() |
9979 | example 13 [US8293903], PF-4634817, PF04634817, PF4634817 | ||||||
PF-04859989 |
![]() |
9038 | compound 1 [PMID: 23466229] | ||||||
PF-04905428 |
![]() |
9062 | CE-224,535, CE-224535, compound 3 [PMID: 21782426], compound 33 [PMID: 21565499] | ||||||
PF-04957325 |
![]() |
9659 | |||||||
PF-06263276 |
![]() |
![]() |
9432 | compound 2 [PMID: 27983835], PF 0626327, PF0626327 | |||||
PF-06282999 |
![]() |
10053 | compound 8 [PMID: 26509551], PF06282999 | ||||||
PF-06426779 |
![]() |
9666 | example 189 [WO2015150995], example 38 [PMID:28498658] | ||||||
PF-06840003 |
![]() |
9565 | EOS200271, PF06840003 | ||||||
PF‐06928215 |
![]() |
11324 | |||||||
PF-07038124 |
![]() |
11950 | Example 4 [US2020108083A1], PF07038124 | ||||||
PF-07054894 |
![]() |
12765 | PF07054894 | ||||||
PF-152 |
![]() |
9014 | compound 43a, example 64 [WO2009016498], PF152 | ||||||
PFK15 |
![]() |
9562 | PFK-015 | ||||||
PH-797804 |
![]() |
![]() |
7818 | ||||||
PHA-408 |
![]() |
9398 | PHA408 | ||||||
phenylbutazone |
![]() |
![]() |
![]() |
7270 | Butazolidine® | ||||
piclamilast |
![]() |
![]() |
11627 | RP 73401, RP-73-401, RP73401 | |||||
piclidenoson |
![]() |
![]() |
422 | IB-MECA, CF 101, CF101, N(6)-ibamu | |||||
pirfenidone |
![]() |
![]() |
7532 | AMR-69, Esbriet® | |||||
piroxicam |
![]() |
![]() |
7273 | CP-16171, Feldene® | |||||
pirtobrutinib |
![]() |
![]() |
![]() |
11628 | BTK inhibitor 16, Jaypirca®, LOXO-305, LOXO305, MCL-133, MCL133, RXC005 | ||||
pixatimod |
![]() |
9870 | compound 18 [PMID: 22458531], PG-545, PG545 | ||||||
PJ34 |
![]() |
![]() |
11348 | PJ-34 | |||||
PKCθ inhibitor 14 |
![]() |
9452 | compound 14 [PMID: 27117263] | ||||||
PKUMDL_MH_1001 |
![]() |
9141 | |||||||
plerixafor |
![]() |
![]() |
![]() |
844 | AMD 3100, AMD3100, bicyclam JM-2987, JM 3100, Mozobil® | ||||
PLX5622 |
![]() |
![]() |
9105 | PLX 5622, PLX-5622 | |||||
PLX7486 |
![]() |
9104 | OPN 7486, OPN-7486, PLX-7486 | ||||||
(S)-23 [PMID: 27933945] |
![]() |
![]() |
9796 | ||||||
PN10 |
![]() |
10089 | |||||||
PO-322 |
![]() |
10739 | 1H-indole-2,3-dione 3-(1,3-benzoxazol-2-ylhydrazone), PO322 | ||||||
polmacoxib |
![]() |
![]() |
![]() |
8316 | Acelex® (S. Korea), CG-100649, CG100649 | ||||
pomalidomide |
![]() |
![]() |
7348 | CC-4047, IMID-3, Imnovid®, Pomalyst® | |||||
POM2-C-HMBP |
![]() |
9616 | |||||||
ponatinib |
![]() |
![]() |
![]() |
5890 | AP24534, Iclusig® | ||||
ponesimod |
![]() |
![]() |
9320 | ACT-128800, ACT128800, Compound 8bo [PMID:20446681], Ponvory® | |||||
poseltinib |
![]() |
9862 | Example 228 [WO2011162515A2], HM71224, HM‐71224, LY333764 | ||||||
povorcitinib |
![]() |
11881 | compound 7 [US20210238168A1] | ||||||
PP2 |
![]() |
9404 | |||||||
PQA-18 |
![]() |
9454 | |||||||
praliciguat |
![]() |
9900 | IW-1973, IW1973 | ||||||
pralnacasan |
![]() |
6467 | VX-740, VX740 | ||||||
pranlukast |
![]() |
![]() |
![]() |
3634 | ONO RS-411 | ||||
prednicarbate |
![]() |
![]() |
7605 | Dermatop®, Hoe 777, Hoe-777, S-770777 | |||||
prednisolone |
![]() |
![]() |
![]() |
2866 | DELTA.1-Cortisol, Orapred®, Pediapred® | ||||
prednisone |
![]() |
![]() |
7096 | Lodotra®, Sterapred® | |||||
preladenant |
![]() |
5614 | SCH-420814, SCH420814 | ||||||
PRN694 |
![]() |
9285 | |||||||
procaterol |
![]() |
![]() |
3464 | ||||||
PSB1115 |
![]() |
3286 | compound 17 [PMID: 11906291], PSB 1115, PSB-1115 | ||||||
PSB-17365 |
![]() |
9871 | compound 48 [Pillaiyar et al., 2018], PSB17365 | ||||||
PSB-KD107 |
![]() |
11081 | compound 2Ak [PMID: 17827019], compound 5 [Schoeder et al., 2020] | ||||||
psora-4 |
![]() |
9583 | 5-(4-phenylbutoxy)psoralen, psora 4 | ||||||
PXS-4681A |
![]() |
9753 | |||||||
PXS-4728A |
![]() |
9346 | PXS4728A | ||||||
P2Y14R antagonist I-17 |
![]() |
13422 | compound I-17 [PMID: 38874515] | ||||||
2-pyridylethylamine |
![]() |
1197 | PEA | ||||||
Q | Back to top | ||||||||
QAV680 |
![]() |
8996 | NVP-QAV680 | ||||||
quemliclustat |
![]() |
![]() |
10707 | AB-680, AB680 | |||||
R | Back to top | ||||||||
1R-11 |
![]() |
10138 | |||||||
R283 |
![]() |
10049 | 1,3-Dimethyl-2[(oxopropyl)thio]imidazolium | ||||||
RA839 |
![]() |
![]() |
10487 | compound 7 [PMID: 31411465], RA-839 | |||||
rabeximod |
![]() |
9856 | Rob-803, Rob803 | ||||||
rebastinib |
![]() |
![]() |
9173 | DCC 2036, DCC-2036, DP-1919 | |||||
remibrutinib |
![]() |
10457 | compound 25 [PMID: 32083858], example 6 [WO2015079417A1], LOU-064, LOU064, LOU064-NXA, NVP-LOU064-NXA | ||||||
reparixin |
![]() |
8498 | DF 1681Y, repertaxin | ||||||
reproxalap |
![]() |
10613 | ADX-102, ADX102, example 5 [WO2018039197A1], NS-2, NS2 | ||||||
resatorvid |
![]() |
9036 | TAK-242, TAK242 | ||||||
resiquimod |
![]() |
![]() |
5051 | R-848, R848 | |||||
[3H]resolvin D1 |
![]() |
![]() |
![]() |
4356 | [3H]-RvD1 | ||||
[3H]resolvin E1 |
![]() |
![]() |
![]() |
2901 | [(3)H]-labeled RvE1, [3H]RvE1 | ||||
revamilast |
![]() |
9865 | Example 26 [WO2006064355A2], GRC 4039, GRC-4039, GRC4039 | ||||||
RG7112 |
![]() |
![]() |
9599 | ||||||
rilapladib |
![]() |
7376 | SB 659032 | ||||||
rilzabrutinib |
![]() |
![]() |
9993 | Example 31 [WO2014039899], PRN-1008, PRN1008 | |||||
rimacalib |
![]() |
9364 | SMP-114 | ||||||
RIPA-56 |
![]() |
9643 | compound 56 [PMID: 27992216], compound 92 [WO2016101885] | ||||||
RIPK2 inhibitor 3 |
![]() |
![]() |
10413 | compound 3 [PMID: 31265286], Example 1 [WO2014043446A1], GSK2983559 | |||||
RIPK2 inhibitor 5 |
![]() |
![]() |
10419 | compound 5 [PMID: 31265286] | |||||
RIPK2 inhibitor 8 |
![]() |
9688 | |||||||
RIPK3 inhibitor 18 |
![]() |
10389 | |||||||
RIPK3 inhibitor 42 |
![]() |
10401 | |||||||
ritlecitinib |
![]() |
![]() |
9559 | compound 11 [PMID: 28139931], example 5 [WO2015083028], Litfulo®, PF-06651600, PF06651600 | |||||
Ro26-4550 |
![]() |
5052 | Ro 26-4550, Ro-26-4550 | ||||||
rocbrutinib |
![]() |
12875 | |||||||
rofecoxib |
![]() |
![]() |
![]() |
2893 | Ceoxx®, MK 966, Vioxx® | ||||
roflumilast |
![]() |
![]() |
![]() |
6962 | ARQ-151/Zoryve® (roflumilast cream), BY-217, BYK-20869, Daliresp®, Daxas® | ||||
roflupram |
![]() |
10691 | FFPM, Zl-n-91 | ||||||
rolipram |
![]() |
5260 | (±)-rolipram, (R,S)-rolipram | ||||||
ROMe |
![]() |
6625 | (R)-FTY720 methyl ether, (R)-FTY720-OMe | ||||||
RORC2 inverse agonist 66 [PMID: 30130103] |
![]() |
10078 | example 5 [WO2016046755A1] | ||||||
rosiptor |
![]() |
9249 | AQX-1125, AQX1125 | ||||||
rovazolac |
![]() |
9625 | A-110, ALX-101, example 36 [WO2013130892] | ||||||
RP-101075 |
![]() |
9889 | |||||||
RS-102895 |
![]() |
![]() |
779 | abaucin, RS102895 | |||||
RS-504393 |
![]() |
781 | RS 504393, RS504393 | ||||||
rupatadine |
![]() |
![]() |
10103 | Rinialer®, Rupafin®, UR-12592, UR12592 | |||||
ruxolitinib |
![]() |
![]() |
![]() |
5688 | (R)-ruxolitinib, INC424, INCB 18424, INCB018424, Jakafi®, Jakavi® | ||||
RV1729 |
![]() |
10162 | RV-1729 | ||||||
RV6153 |
![]() |
10163 | RV-6153 | ||||||
RWJ-56423 |
![]() |
![]() |
9333 | (2S)-6 | |||||
S | Back to top | ||||||||
S4-1 |
![]() |
12321 | |||||||
salbutamol |
![]() |
![]() |
558 | albuterol, SCH-13949W, Ventolin® | |||||
salmeterol |
![]() |
![]() |
559 | GR 33343X, Serevent® | |||||
Sanofi-14h |
![]() |
13067 | compound 14h [PMID: 25589934] | ||||||
SAR-20347 |
![]() |
9803 | |||||||
SB202190 |
![]() |
![]() |
4307 | SB 202190, SB-202190 | |||||
SB203580 |
![]() |
5269 | PB 203580, RWJ 64809, SB-203580 | ||||||
SB 225002 |
![]() |
833 | SB-225002, SB225002 | ||||||
SB290157 |
![]() |
3529 | SB-290157 | ||||||
SB328437 |
![]() |
3530 | SB 328437, SB-328437 | ||||||
SC-51089 |
![]() |
1923 | SC 51089 | ||||||
Sch.336 |
![]() |
9799 | analog 4j [PMID: 15664857], SCH-336, SCH336 | ||||||
SD-208 |
![]() |
8246 | SCI-208, SD 208 | ||||||
S-26d [PMID: 37883692] |
![]() |
12979 | |||||||
seletalisib |
![]() |
9800 | UCB 5857, UCB-5857, UCB5857 | ||||||
selinexor |
![]() |
![]() |
10036 | compound 70 [WO2013019561A1], KPT-330, KPT330, Nexpovio®, Xpovio® | |||||
selnoflast |
![]() |
12173 | Example 6 [WO2019008025A1], RG-6418, RG6418 | ||||||
selonsertib |
![]() |
![]() |
9040 | GS-4997 | |||||
S-EMCA |
![]() |
![]() |
7048 | 6α-ethyl-23(S)-methyl-cholic acid, INT-777, INT777 | |||||
serlopitant |
![]() |
9280 | compound 17 (Jiang et al. 2009), VPD-737 | ||||||
setanaxib |
![]() |
9932 | GKT-137831, GKT-831, GKT137831, GKT831 | ||||||
setipiprant |
![]() |
10180 | ACT-129968, ACT129968, compound 28 [PMID: 23721423] | ||||||
setogepram |
![]() |
10043 | 3-pentylbenzeneacetic acid, fezagepras, PBI-4050, PBI4050 | ||||||
SGC-CBP30 |
![]() |
![]() |
![]() |
7529 | |||||
SIAIS178 |
![]() |
10526 | compound 19 [PMID: 31539241], SIAIS-178 | ||||||
siponimod |
![]() |
![]() |
![]() |
9289 | BAF-312, BAF312, compound 32 [PMID: 24900670], Mayzent® | ||||
sirolimus |
![]() |
![]() |
![]() |
6031 | AY-22989, Fyarro® (sirolimus albumin-bound particles), Rapamune®, rapamycin, WY-090217 | ||||
SIRT1 activator 3 |
![]() |
9514 | SA-3, SA3 | ||||||
SLM6071469 |
![]() |
10641 | compound 10 [PMID: 31895563] | ||||||
SNX0723 |
![]() |
![]() |
9260 | ||||||
sofnobrutinib |
![]() |
10094 | compound 4b [PMID: 30216722] | ||||||
solcitinib |
![]() |
9697 | compound 1 [WO2010149771], GLPG-0778, GLPG0778, GSK2586184 | ||||||
sotrastaurin |
![]() |
![]() |
7946 | AEB-071, AEB071 | |||||
sotuletinib |
![]() |
8250 | BLZ 945, BLZ-945, BLZ945 | ||||||
SP-4206 |
![]() |
![]() |
9037 | compound 13 [PMID:12656598], SP4206 | |||||
SP600125 |
![]() |
![]() |
5273 | 1,9-pyrazoloanthrone, JNK Inhibitor II, SP-600125 | |||||
sparsentan |
![]() |
![]() |
8448 | DARA-a (Dual Acting Receptor Antagonist of angiotension and endothelin receptors), BMS-346567, compound 7 [PMID 15634011], Filspari®, RE-021, retrophin | |||||
spebrutinib |
![]() |
7837 | AVL 292, AVL-292, cc-292 | ||||||
sphingomyelin synthase 2 inhibitor 15w |
![]() |
10054 | compound 15w [PMID: 30074791] | ||||||
SPRi3 |
![]() |
![]() |
10130 | example 23 [WO2011047156], SPR inhibitor 3 | |||||
SR1001 |
![]() |
10143 | SR-1001 | ||||||
SR144528 |
![]() |
751 | SR 144528, SR-144528 | ||||||
SR1555 |
![]() |
10145 | SR-1555 | ||||||
SR2211 |
![]() |
![]() |
10144 | SR-2211 | |||||
SR2640 |
![]() |
3329 | SR 2640, SR-2640 | ||||||
SR8185 |
![]() |
9578 | SR-8185 | ||||||
SRT1720 |
![]() |
![]() |
7703 | ||||||
SRT2104 |
![]() |
9515 | compound 4 [Ng et al., 2013], GSK2245840, SRT-2104 | ||||||
SS-208 |
![]() |
![]() |
10490 | compound 7b [PMID: 31414801], SS208 | |||||
STING agonist 2 |
![]() |
![]() |
10127 | ||||||
STING agonist 3 |
![]() |
10128 | compound 3 [PMID: 30405246], diABZI, diABZI STING agonist-1 | ||||||
(R)-STU104 |
![]() |
12006 | (R)-4e [PMID: 35442672] | ||||||
sulindac |
![]() |
![]() |
5425 | Clinoril® | |||||
suprofen |
![]() |
![]() |
7298 | Profenal®, R-25061 | |||||
SX682 |
![]() |
10165 | |||||||
Syk inhibitor |
![]() |
6046 | K00564a, spleen tyrosine kinase inhibitor | ||||||
Syk inhibitor II |
![]() |
6047 | K00592a | ||||||
SZM679 |
![]() |
12311 | SZM-679 | ||||||
T | Back to top | ||||||||
T0901317 |
![]() |
![]() |
2755 | T 0901317, T-0901317 | |||||
TAK-632 |
![]() |
![]() |
10387 | compound 8B [PMID: 23906342], TAK632 | |||||
TAK-715 |
![]() |
![]() |
9328 | compound 8h [PMID: 16162000], TAK 715, TAK0715 | |||||
TAK-779 |
![]() |
783 | TAK779 | ||||||
TAK-981 |
![]() |
11305 | Example 133 [WO2016004136A1], I-263a [WO2016004136A1], subasumstat (proposed INN), TAK981 | ||||||
TAK-828F |
![]() |
![]() |
9867 | compound 10 [PMID: 29510038], TAK-828, TAK828F | |||||
Takinib |
![]() |
![]() |
9655 | ||||||
talabostat |
![]() |
9892 | compound 1 [PMID: 18783201], PT-100, PT100, Val-boro-pro, Val-boroPro | ||||||
talmapimod |
![]() |
![]() |
7817 | SCIO 469 hydrochloride, SCIO-469 | |||||
tamatinib |
![]() |
![]() |
5706 | R 406, R-406, R406 free base | |||||
tanespimycin |
![]() |
7751 | 17-AAG, 17-allylamino-17-demethoxygeldanamycin, 17-N-allylamino-17-demethoxygeldanamycin, 17AAG, compound 4 [PMID:15978816] | ||||||
tanzisertib |
![]() |
9836 | CC-930, CC930, compound 1 [PMID: 22244937] | ||||||
tapinarof |
![]() |
![]() |
9686 | GSK-2894512, GSK2894512, Vtama®, WB-1001, WBI 1001, WBI-1001 | |||||
TAS05567 |
![]() |
9941 | |||||||
telotristat ethyl |
![]() |
![]() |
9490 | LX-1606, LX1606, Xermelo® | |||||
tenalisib |
![]() |
9907 | RP-6530, RP6530 | ||||||
teneligliptin |
![]() |
![]() |
![]() |
9906 | compound 8g [PMID: 22959556], MP-513, MP513, Teneli | ||||
tepilamide fumarate |
![]() |
9770 | XP 23829, XP-23829, XP23829 | ||||||
TEPP-46 |
![]() |
10555 | compound 46 [PMID: 20451379], ML-265, ML265, TEPP46 | ||||||
terfenadine |
![]() |
![]() |
2608 | RMI-9918, Seldane®, Triludan® | |||||
teriflunomide |
![]() |
![]() |
![]() |
6844 | A77 1726, Aubagio®, flucyamide, HMR-1726 | ||||
tetomilast |
![]() |
9877 | compound 19f [PMID: 7830278], OPC-6535, OPC6535 | ||||||
TG11-77 |
![]() |
10603 | compound 20o [PMID: 31904232] | ||||||
TG6-129 |
![]() |
9283 | |||||||
TG8-260 |
![]() |
12520 | compound 2f [PMID: 35187419], TG8260 | ||||||
TH5487 |
![]() |
![]() |
10184 | TH-5487 | |||||
thalidomide |
![]() |
![]() |
7327 | K-17 | |||||
tigemocoxib |
![]() |
![]() |
13505 | 29b-(S) [PMID: 20709553], SC-75416, SC75416 | |||||
timapiprant |
![]() |
9277 | OC000459, OC459 | ||||||
tiotropium |
![]() |
![]() |
367 | BA-679-BR, Spiriva® | |||||
tirabrutinib |
![]() |
![]() |
9265 | GS-4059, ONO-4059, ONO4059, Velexbru® | |||||
TK05 |
![]() |
9556 | |||||||
TM30089 |
![]() |
1905 | CAY 10471, CAY-10471, CAY10471 | ||||||
tofacitinib |
![]() |
![]() |
![]() |
5677 | CP-690,550, CP-690550, tasocitinib, Xeljanz® | ||||
tolebrutinib |
![]() |
10625 | BTK'168, example 3 [WO2016196840A1], PRN-2246, PRN2246, SAR442168 | ||||||
tolmetin |
![]() |
![]() |
![]() |
7311 | MCN-2559, McN-2559-21-98, Tolectin® | ||||
tomivosertib |
![]() |
![]() |
10167 | compound 23 [PMID: 29526098], eFT-508, eFT508 | |||||
toreforant |
![]() |
9276 | JNJ-38518168 | ||||||
tradipitant |
![]() |
9278 | LY-686017, LY686017, VLY-686 | ||||||
TRAM-34 |
![]() |
2336 | |||||||
tranilast |
![]() |
![]() |
![]() |
6326 | MK-341, SB-252218 | ||||
triamcinolone |
![]() |
![]() |
2870 | fluoxiprednisolone, Kenalog®, Nasacort® | |||||
triamcinolone acetonide |
![]() |
![]() |
![]() |
2867 | Zilretta® | ||||
trifarotene |
![]() |
![]() |
![]() |
9962 | Aklief®, CD5789, compound 15b [PMID: 29706423] | ||||
trilaciclib |
![]() |
![]() |
9626 | Cosela®, G1T28 | |||||
tripelennamine |
![]() |
![]() |
7318 | Pyribenzamine® | |||||
triple modulator 10 [PMID: 29878767] |
![]() |
10002 | |||||||
tryptanthrin 5i |
![]() |
10126 | compound 5i [PMID: 24099220] | ||||||
tubastatin A |
![]() |
![]() |
9702 | ||||||
TUG-1375 |
![]() |
10107 | compound 31 [PMID: 30247908], TUG1375 | ||||||
TY-51469 |
![]() |
9779 | |||||||
TYK2 inhibitor 14l |
![]() |
11425 | |||||||
U | Back to top | ||||||||
U46619 |
![]() |
![]() |
1888 | 11α,9α-epoxymethano-PGH2, U 46619, U-46619 | |||||
umbralisib |
![]() |
![]() |
8916 | example A1 [US2014011819], RP-5264, RP5264, TGR-1202, TGR1202, Ukoniq® | |||||
umeclidinium |
![]() |
![]() |
7354 | GSK573719A, Incruse Ellipta® | |||||
UNC4203 |
![]() |
10131 | MERTK inhibitor 19 [PMID: 30347155], UNC4203A [US20150291606A1] | ||||||
upadacitinib |
![]() |
![]() |
9246 | ABT-494, Rinvoq® | |||||
uracil 20 |
![]() |
9901 | |||||||
usnoflast |
![]() |
12883 | Example-6 [WO2020148619A1], ZY-IL1, ZYIL-1, ZYIL1 | ||||||
V | Back to top | ||||||||
vactosertib |
![]() |
![]() |
8107 | EW-7197, EW7197, NOV-1301, TEW-7197 | |||||
valategrast |
![]() |
11487 | R-411, RO-0272441 | ||||||
valdecoxib |
![]() |
![]() |
![]() |
2894 | Bextra®, SC-65872 | ||||
vamorolone |
![]() |
![]() |
9247 | Agamree®, VBP-15, VBP15 | |||||
vanin-1 inhibitor [PMID: 33196323] |
![]() |
11718 | example 1 [WO2016193844A1] | ||||||
varespladib |
![]() |
![]() |
9657 | compound 6m [PMID: 8978844], LY315920, S-5920, varespladib methyl (A-002), varespladib sodium (A-001) | |||||
VCE-004.3 |
![]() |
10030 | |||||||
vecabrutinib |
![]() |
10231 | BIIB-062, BIIB062, SNS-062, SNS062 | ||||||
velsecorat |
![]() |
![]() |
9325 | AZ13189620, AZD7594, compound 15m [PMID: 28937774] | |||||
vemurafenib |
![]() |
![]() |
![]() |
5893 | PLX4032, RG7204, Zelboraf® | ||||
venetoclax |
![]() |
![]() |
![]() |
8318 | ABT-199, GDC-0199, Venclexta®, Venclyxto® | ||||
vercirnon |
![]() |
![]() |
9046 | CCX282-B, GSK'786, GSK1605786, GSK1605786A, Traficet-EN | |||||
verdiperstat |
![]() |
![]() |
10052 | AZD-3241, AZD3241 | |||||
verlukast |
![]() |
6193 | MK-679, MK679 | ||||||
vidofludimus |
![]() |
![]() |
9860 | 4SC-101, IMU-838 (vidofludimus calcium), SC12267 | |||||
vidupiprant |
![]() |
10169 | AMG 853, AMG-853, AMG853, compound 2 [PMID: 24900313] | ||||||
vilanterol |
![]() |
![]() |
7353 | GW642444X | |||||
vimnerixin |
![]() |
12100 | AZD-4721, AZD4721, compound 4 [WO2019055509A1], RIST4721 | ||||||
vipadenant |
![]() |
![]() |
5612 | BIIB 014, BIIB014, V2006 | |||||
vipoglanstat |
![]() |
12209 | BI 1029539, BI-1029539, BI1029539, GS-248, GS248 | ||||||
vortioxetine |
![]() |
![]() |
![]() |
7351 | Brintellix®, compound 5m [PMID: 21486038], Lu AA21004, Trintellix® | ||||
VRT-043198 |
![]() |
![]() |
9034 | ||||||
VX-702 |
![]() |
6059 | I14-1965, VX 702, VX702 | ||||||
W | Back to top | ||||||||
1400W |
![]() |
![]() |
5102 | W 1400 | |||||
WH-4-023 |
![]() |
8068 | |||||||
WJYK50 |
![]() |
10639 | compound 1c [PMID: 29649738] | ||||||
WN1703 |
![]() |
13463 | compound 16c [PMID: 28918097], WN-1703, XOR inhibitor 16c | ||||||
WXFL10203614 |
![]() |
12621 | WX614, WXFL-10203614 | ||||||
Y | Back to top | ||||||||
YM90709 |
![]() |
5090 | YM 90709, YM-90709 | ||||||
Z | Back to top | ||||||||
zabedosertib |
![]() |
11415 | BAY-1834845, BAY1834845 | ||||||
zafirlukast |
![]() |
![]() |
![]() |
3322 | Accolate®, ICI-204219 | ||||
zaloglanstat |
![]() |
11406 | |||||||
zanubrutinib |
![]() |
![]() |
9861 | BGB-3111, BGB3111, Brukinsa®, compound 27b [US9447106] | |||||
zasocitinib |
![]() |
![]() |
12155 | compound I-908 [US20190256519A1], NDI-034858, NDI034858, TAK-279, TAK279 | |||||
zaurategrast |
![]() |
11488 | CDP-323, CDP323 | ||||||
zelebrudomide |
![]() |
13490 | compound 28 [PMID: 38300987], NX-2127, NX2127 | ||||||
zelnecirnon |
![]() |
12893 | example 37 [WO2019147862A1], RPT-193, RPT193 | ||||||
zemprocitinib |
![]() |
13221 | compound 1 [US20220009927] | ||||||
zenuzolac |
![]() |
11682 | (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, GIT-027, GIT-27, GIT27, GLS-1027, GLS1027, rac-[(5R)-3-phenyl-4,5-dihydro-1,2-oxazol-5-yl]acetic acid, VGX-1027, VGX1027 | ||||||
zetomipzomib |
![]() |
10409 | compound 12 [PMID: 30380863], KZR-616, KZR616 | ||||||
zileuton |
![]() |
![]() |
5297 | A-64077, ZYFLO® | |||||
zimlovisertib |
![]() |
![]() |
9667 | compound 40 [PMID: 28498658], PF-06650833, PF06650833 | |||||
(R)-ZINC-3573 |
![]() |
![]() |
9566 | ZINC-72453573 | |||||
ziritaxestat |
![]() |
![]() |
9561 | compound 11 [PMID: 28414242], GLPG-1690, GLPG1690 | |||||
ZK 756326 |
![]() |
![]() |
813 | ZK-756326, ZK756326 | |||||
ZLN005 |
![]() |
13255 | ZLN 005, ZLN-005 | ||||||
zomiradomide |
![]() |
11904 | compound A [WO2022027058A1] | ||||||